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ABSTRACT
INVESTIGATING AGE-RELATED MACULAR DEGENERATION: A CHEMISTRY PLUS
BIOLOGY APPROACH

Jennifer C. Tournear, PhD
Department of Chemistry and Biochemistry
Northern Illinois University 2018
Elizabeth R. Gaillard, Director

Age-related macular degeneration (AMD) is a retinal disease that can cause severe vision
loss. It is responsible for the majority of blindness in developed countries in the elderly
population. The disease is characteristically multifactorial where oxidative stress, inflammation
and retinal lipofuscin (cellular waste product) accumulation have been indicated in disease
progression. The retinal pigment epithelial (RPE) attaches to the Bruch’s membrane (BM) and
the symbiotic relationship between these two layers of the retina is essential for the visual cycle
to function normally. Retinal lipofuscin is believed to contribute to drusen (characteristic
deposits in the AMD BM) that negatively impact the BM and, in turn, the retina. Investigating
the biological changes to the retina that are catalyzed by chemical reactions, such as
photooxidation, can help to further the understanding of AMD.
It is believed that when the BM is significantly modified, the RPE cells detach and
undergo cell death. Retinal cell death is a hallmark of AMD. This work includes the
investigation of ARPE-19 cell death when extracellular matrix (ECM) has been modified to

model AMD through oxidative stress, aging and inflammation. Results indicate overlapping cell
death pathways are activated as a result of ECM modification including proinflammatory cell
death mechanisms: pyroptosis and necroptosis.
Lipofuscin extracts obtained from human donor eyes where donors were previously
diagnosed with one of three retinal diseases (wet AMD, dry AMD or diabetic retinopathy) are
investigated using liquid chromatography mass spectrometry. Photooxidation products,
inflammatory biomarkers and aging biomarkers are investigated as being components making up
lipofuscin. Specifically, the observation of these components in association with a particular
retinal disease is examined. Results indicate trends associated with oxidative stress markers
being linked to wet AMD samples and inflammatory biomarkers being mostly associated with
dry AMD samples.
This work uses a two-prong approach to explore AMD onset and progression. Through
the investigation of cell death using disease models and the components of lipofuscin buildup in
human tissue, we begin to identify the impact and consequences these biological changes have
on the retina.
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CHAPTER 1
INTRODUCTION
The leading cause of irreversible blindness in developed countries is age-related macular
degeneration (AMD). The disease is commonly categorized as either early or advanced stage
AMD. Advanced AMD can be classified into two different types: nonexudative (dry) AMD and
exudative (wet) AMD (Coleman, Chan, Ferris, & Chew, 2008; De Jong, 2006). Dry AMD
begins with drusen, defined pigmented granules, near the fovea causing gaps in the patient’s
vision. Wet AMD is characterized by the abnormal growth of leaking blood vessels into the
retinal layers at the back of the eye. Vision impairment begins rapidly, and as the disease
progresses, additional hemorrhaging, scarring and permanent vision loss occur (Binder &
Falkner-Radler, 2008; De Jong, 2006).
It has been estimated that nearly 11 million people in the United States are living with
some form of AMD. Approximately 8 million Americans are reported as being affected by the
early stages of AMD; a diagnosis that puts them at a higher risk for developing more advanced
stages of AMD (Friedman et al., 2004; Jonas, 2014; B. E. K. Klein & Klein, 2009; NEI, 2016).
The National Eye Institute projects that the cases of advanced AMD in the United States will
more than double from year 2010 to year 2050 (figure 1.1). Globally it is estimated the number
of AMD cases will reach 196 million by the year 2020 (Jonas, 2014).
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Figure 1.1: AMD cases and projections indicating risk factors associated with ethnicity (NEI,
2016).

Many risk factors have been correlated with the onset and progression of AMD including age, 3
gender, race, oxidative stress and inflammation (Coleman et al., 2008; De Jong, 2006; Murdaugh
et al., 2011; NEI, 2016). The molecular basis of the disease is not fully understood so treatment
and prevention options are very limited (Gehrs, Anderson, Johnson, & Hageman, 2006;
Murdaugh et al., 2011). Treatment options include intravitreal injections for the angiogenesis
associated with wet AMD and diabetic retinopathy. High risk patients may take a formulation of
antioxidant multivitamins for the eye called the AREDS formulation, but the use of these
vitamins have been inconclusive in preventing AMD. There are currently no treatment options
for dry AMD. Patients diagnosed with wet AMD have an option for prescription injection
treatments using pharmaceuticals like ranibizumab; however, this is not a permanent treatment
nor does it significantly reverse disease. These treatments are costly and have poor patient
compliance.
AMD is described as a multifactorial disease that is strongly correlated with aging,
inflammation and oxidative stress. The exact mechanism that leads to the onset of wet or dry
AMD remains unknown. It has been suggested that age-related changes, inflammation and
oxidative stress affecting the retinal pigment epithelium (RPE) and Bruch’s Membrane (BM)
may play a critical role in the development of AMD. Therefore, age-related changes that accrue
with time are explored in this work. Additionally, enhanced treatment options intended for
patients diagnosed with wet AMD are investigated.
The Visual System
The eye is a complex sensory organ that consists of a number of components working
together allowing an organism to see. In order for an organism to see, the light waves from

another source are focused sharply upon the retina. A traverse section of a human eye is
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illustrated in figure 1.2. The anatomy of the eye is sectioned into three layers: the outer layer, the
middle layer and the inner layer. The outer layer is made up of the sclera and the cornea. The
middle layer consists of the choroid coat, the ciliary body, the lens, and the iris. The third layer
consists of the retina and the space between the second and third layer is a jelly-like fluid known
as the vitreous body. In a normal functioning eye, reflected light waves enter the eye through the
pupil where the cornea and the lens focus the light upon the retina. The photoreceptors in the
retina absorb the light through a series of biochemical processes that generates electrochemical
signals. The electrochemical signals are delivered to the visual cortex through the optic nerve
where an image can be processed (Shier, Butler, & Lewis, 2007).
The cornea is a transparent tissue that serves as a protective layer for the anterior segment
of the eye and assists the lens in focusing light to the retina. The cornea is composed of five
layers including the epithelium, Bowman’s membrane, the stroma, Descemont’s membrane and
the endothelium. The convex surfaces of the cornea and lens refract the light waves entering the
eye where the cornea is responsible for up to 75% of the focusing. The lens acts as a fine-tuned
focus that accommodates for the divergent light waves originating at closer distances. These
accommodations are made by the ciliary muscles relaxing, which allow the lens to thicken and
converge the light more strongly (Murdaugh, 2010; Shier et al., 2007; M. Thao, 2014). Because
of molecules that absorb light from 295-400 nm, the lens acts as a UV-filter only allowing light
waves longer than 400 nm to reach the retina (Dillon, Zheng, Merriam, & Gaillard, 2004; Dillon,
Zheng, Merriam, & Gaillard, 1999). The iris controls the amount of light that enters the eye. The
brightness of the light stimulates muscles to constrict which causes the pupil to dilate in dim light
conditions and constrict in bright light conditions.
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Figure 1.2: Anatomy of the human eye (NEI, 2016).

This effectively changes the field of view, the depth of focus and the intensity of the image.
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The retina is a complex, multi-layered structure located at the posterior of the eye. Figure
1.3 depicts the layers of the retina. When light is focused onto the retina, it must first enter
through the ganglion cell layer and bipolar neurons before reaching the photoreceptors (PR). The
PRs are the neurons responsible for the detection of light to initiate visual perception. The retina
absorbs about 1012-1015 photons per day. There are two types of PRs classified by their
morphological appearance: rods and cones. In addition to morphological appearance, rods and
cones have specific functional properties, light sensitivities, response kinetics and adaption
range. Humans have a rod to cone ratio of 95:5 where the fovea is populated exclusively by
cones. Thus, cones are strongly associated with high visual acuity. The macula is an area found
in and around the fovea where damage to this area can cause severe photoreceptor loss resulting
in central vision impairment (Lambert et al., 2016). Rods are exceptionally sensitive to light
stimuli, where they are able to detect a single photon of light. As such, rods are more active in
dim light conditions and they photobleach very readily. In contrast, cones are less sensitive to
bright light and recover very rapidly under bright light conditions. Each PR is activated by a
particular visual pigment consisting of a light-sensing chromophore covalently bonded to a
protein that determines the spectral sensitivity of the PR. The most common chromophore is 11cis retinal. Rods contain the visual pigment rhodopsin and cones contain cone pigment. There
are three different types of cone PRs: short (blue), medium (green) and long (red). Each type of
cone contains a specific pigment that responds to a particular wavelength of light responsible for
color vision; the short responds to wavelengths from 400-500 nm, the medium responds to
wavelengths from 450-630 nm and the long responds to wavelengths from 500-700 nm (Hunter
et al., 2012; Murdaugh, 2010; J. S. Wang & Kefalov, 2011).
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Figure 1.3: The retinal layers. (A) Illustration of all ten retinal layers. (B) Light micrograph of
full-thickness view of the retina (Remington, 2005).

The biochemical conversion of a photon absorbed by the visual pigments into an
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electrical signal is known as the visual cycle. There are two types of visual cycles believed to
occur in the retina: the classic visual cycle and the newly emerging cone-specific visual cycle.
The classic visual cycle occurs with a series of isomerizations between the RPE and the PR.
After the absorption of light by visual pigments, 11-cis retinal undergoes isomerization to the alltrans configuration. The molecule, 11-cis retinal, serves as an antagonist in dark conditions and
binds to opsin with a Schiff base linkage. Isomerization to the trans configuration occurs as a
photochemical reaction where the all-trans retinal is a strong agonist for opsin and occurs within
1 ms. The Schiff base is dissociated with a hydrolysis reaction to produce all-trans retinal and
free opsin. The all-trans retinal is reduced to all-trans retinol through the combined actions of
RDH8 and RDH12. All-trans retinol is transported to the RPE where it is enzymatically
esterified into retinyl ester with lecithin retinol acyltransferase (LRAT). Retinyl ester is the
substrate for RPE65, an isomerhydrolase, where RPE65 coverts the ester to 11-cis retinol. The
11-cis retinol is oxidized back to 11-cis retinal and is transported back to the PR to regenerate
visual pigments. Figure 1.4 displays the chemical structures involved in the visual cycle. The
shuttling of the retinoids is aided by interphotoreceptor retinoid binding protein (IRBP).
Recently, the cone visual cycle has been proposed as an RPE65 independent cycle. In the cone
PR, the isomerization of all-trans retinol is proposed to occur in the Müller cells where
dihydroceramide desaturase-1 (DES1) assists in a direct isomerization of all-trans retinol to 11cis retinol (Kaylor et al., 2013; Tang, Kono, Koutalos, Ablonczy, & Crouch, 2013; J. S. Wang &
Kefalov, 2011). Figure 1.5 illustrates the proposed rod and cone visual cycles. Damage to the
PRs, the RPE and disruptions in the visual cycle have been correlated with ocular disease and
can lead to severe vision loss.
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Figure 1.4: Synthesis of 11-cis retinal from β-carotene and recycling of all-trans retinal. (1) 11cis retinal, (2) β-carotene, (3) all-trans retinal, (4) all-trans retinol, (5) all-trans retinyl ester, (6)
11-cis retinol.
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A

B

Figure 1.5: Illustration of proposed visual cycles. (A) Rod visual cycle, (B) Cone visual cycle (J.
S. Wang & Kefalov, 2011).

The RPE is the last layer of the retina where the basal surface is associated with Bruch’s

11

membrane (BM). BM is a multi-layer tissue that separates the RPE from the choroid. The
choroid is composed of four different layers, each with different sizes of blood vessels. The
blood vessels supply the eye with oxygen and nutrients. Angiogenesis of the choroicapillaris is
highly correlated with retinal disease.
Retinal Pigment Epithelium
The RPE is a cuboidal pigmented monolayer of hexagonal cells located between the
photoreceptors and BM (Cavallotti & Schveoller, 2008; Gu et al., 2012). RPE cells are
polarized, post-mitotic and are involved in several roles to maintain the visual cycle and perform
highly specialized functions essential for maintaining retinal homeostasis. The polarization
allows for the cell to perform these functions asymmetrically (Bhutto & Lutty, 2012; Cavallotti
& Schveoller, 2008; Gu et al., 2012; J R Sparrow, Hicks, & Hamel, 2010; Strauss, 2005; Sun et
al., 2007).
Each human eye contains 4-6 million RPE cells that extend from the root of the iris to the
ora serrata (Bhutto & Lutty, 2012; Cavallotti & Schveoller, 2008). In the central part of the retina
the RPE cells are uniform in shape and dimension; at the equator, cells are taller and larger and
at the extreme periphery the cells lose their uniformity. General aging has shown a loss of about
2.3% of RPE cells per decade of life; however, this loss is not observed in the fovea. This is
thought to be attributed to the periphery cells replenishing the fovea RPE as the retina ages
(Cavallotti & Schveoller, 2008; J R Sparrow et al., 2010). RPE cells are tightly packed where the
lateral border serves as sites of cell-cell adhesion and cell communication mediated by cadherins
(figure 1.6) (Cavallotti & Schveoller, 2008; Sun et al., 2007).
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Figure 1.6: Confocal microscopy image of human RPE cells in culture with ZO-1 staining
showing hexagonal shape and tight junctions (J. Zhou et al., 2010).

Apical junctions, adherans and gap junctions limit passage of molecules and ions through the 13
paracellular space therefore forming the outer blood-retinal barrier (J R Sparrow et al., 2010).
The apical RPE contain microvilli that project into the interphotoreceptor matrix. The
microvilli interact with the distal tips of the PR outer segments (Cavallotti & Schveoller, 2008;
Gu et al., 2012; J R Sparrow et al., 2010; Strauss, 2005; Sun et al., 2007). The apical microvilli
play a key role in mediating functions required for retinal homeostasis. These highly specialized
functions include phagocytosis of PR outer segments, directional transport of nutrients into PR
and removal of waste products from the PR cells (J R Sparrow et al., 2010; Sun et al., 2007).
Rod outer segments are regenerated every 7-10 days, and the RPE actively participates in the PR
turnover. The RPE role of PR turnover involves catabolic activity where the RPE remove the
weakened membrane, digest the material and recycle some of the components back to the PR (J
R Sparrow et al., 2010; Strauss, 2005). In order to remove the PR waste, the RPE is capable of
either recycling it or completely degrading it (figure 1.7). In addition to recycling the waste back
to the PR, the RPE can also exocytose the remains for the choriocapillaris to clear the waste from
the retina (Bhutto & Lutty, 2012). It is thought that the incomplete digestion of the PR outer
segments may contribute to the build-up of lipofuscin in the RPE.
In addition to the crucial phagocytic activity of the RPE, the ion channels present are
essential for function of the visual cycle. The sodium gradient channel is central to this activity.
The sodium/potassium adenosine triphosphatase protein creates a high Na+ concentration in the
sub retinal space and a high concentration of K+ within the RPE cytosol. The Na+ is required to
sustain the dark current of the PRs, where the ions can open the cGMP-gated channels and
depolarize the PRs (Rajasekaran et al., 2003; J R Sparrow et al., 2010; Strauss, 2005).
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Figure 1.7: A depiction of the phagocytic function of RPE cells. The diagram displays the
possible formation of lipofuscin from the incomplete digestion of the outer segments (Kennedy,
Rakoczy, & Constable, 1995).

The RPE is responsible for supplying and transporting ions, water, amino acids, ascorbic acid, 15
omega-3 fatty acids and glucose to the outer retinal environment. Several proteins are associated
with the RPE in order to achieve these functions. These processes are depicted in figure 1.8.
The basal surface of the RPE is highly folded and interacts with BM by the basal lamina
layer. Structural integrity of the choroicapillaris, the neural retina and BM are dependent on
proper attachment of the RPE cells. Attachment is mediated by integrin receptors on the RPE and
ligands within the basal lamina. These ligands are present in laminin, fibronectin and collagen
type IV (Bhutto & Lutty, 2012; Cavallotti & Schveoller, 2008; Gu et al., 2012; Sun et al., 2007).
The proteins present in the RPE basal surface also regulate the exchange of nutrients and
signaling molecules between the RPE and choroid; therefore, assisting in the establishment of the
blood-retinal barrier (Gu et al., 2012; Strauss, 2005). Several growth factors known to be
produced and secreted from the RPE help build and sustain the choroid and photoreceptors.
These include: fibroblast growth factors (FGF-1, FGF-2, and FGF-5), transforming growth
factor-β (TGF-β), insulin-like growth factor-I (IGF-I), ciliary neurotropic factor (CNTF),
platelet-derived growth factor (PDGF), VEGF, lens epithelium-derived growth factor (LEDGF),
members of the interleukin family, and pigment epithelium-derived factor (PEDF) (Bhutto &
Lutty, 2012; Kase et al., 2010; Strauss, 2005).
Bruch’s Membrane
The basement membrane of the RPE has a fibrillar quality with some fibrils extending
into the inner portions of BM. In addition to the integrin-protein interactions between the RPE
and BM, it is believed the fibril interactions assist in the structural stability between the two
tissues (Zinn & Benjamin-Henkind, 1979).
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Figure 1.8: Illustration of several transport RPE functions (Strauss, 2005).

BM is a thin, acellular and multi-layered extracellular matrix that separates the basal surface 17
of the RPE from the choriocapillaris. The membrane extends from the posterior section of the
eye to the ora serrata. It is interrupted only by the optic nerve. The thickness of BM is not
uniform throughout its makeup. It is thicker (2-4 µm) in the optic nerve region and thins (1-2
µm) in the retinal periphery (Curcio & Johnson, 2013; Zinn & Benjamin-Henkind, 1979).
BM has five distinct layers that are made up of specific components. The five layers
include: the RPE basal lamina, the inner collagenous layer, the elastic layer, the outer
collagenous layer and the choriocapillaris basal lamina (Figure 1.9). The RPE basal lamina
contains fine fibers composed of collagen IV α3-5. As previously discussed the RPE and BM
have a symbiotic relationship. One of these relationships is the requirement for RPE to adhere to
BM. The RPE synthesizes specific laminins that preferentially adhere to the RPE basal lamina
through integrin interactions (Aisenbrey et al., 2006; Zinn & Benjamin-Henkind, 1979). The
inner collagenous layer contains a multilayer crisscross system of collagens I, III and V that lie
parallel to the plane of BM. This layer of BM is particularly associated with charged molecules
which include the negatively charged proteoglycans chondroitin sulfate and dermatan sulfate
(Call & Hollyfield, 1990; Tyl Hewitt, Nakazawa, & Newsome, 1989; Zinn & BenjaminHenkind, 1979). The elastic layer contains stacked linear elastin fibers, collagen VI, fibronectin,
and collagen fibers from the inner collagenous layer. The functions of the elastic layer include
regulation of biomechanical properties, vascular compliance and antiangiogenic barrier functions
(Korte & D’Aversa, 1989; Zinn & Benjamin-Henkind, 1979). The outer collagenous layer
contains many of the same components as the inner collagenous layer, where the collagen fibrils
run parallel to the choriocapillaris.
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RPE basal lamina
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Outer collagenous layer
Choriocapillaris basal lamina

Figure 1.9: Illustration of location of BM within the retina and the five layers that make up BM
(Curcio & Johnson, 2013).

Specific to the outer collagenous layer, there are periodic outward extensions between
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intercapillary pillars (Newsome, Huh, & Green, 1987; Zinn & Benjamin-Henkind, 1979). The
final layer is the choriocapillaris basal lamina consisting of collagen IV α1-2, V, VI and laminin.
It is thought that this layer may inhibit endothelial cell migration into BM.
The primary function of BM is structural; however, it also functions to assist fluid and
macromolecular transportation between the RPE and choroicapillaris. In order to serve as an
integral structural support for the retina, BM requires elasticity. BM is known to withstand
stretch and return to its original shape under conditions such as inter ocular pressure changes and
choroid blood volume changes (Curcio & Johnson, 2013; Zinn & Benjamin-Henkind, 1979). As
the choroid serves the metabolic needs of the outer retina, exchange of oxygen, nutrients,
electrolytes and cytokines must pass through the BM to be received by the RPE and PRs. Fluid is
pumped from the sub retinal space by the RPE at a rate of 11 µL/hr/cm2 (Chihara & Nao-i,
1985). This fluid must also flow across BM to reach circulation; therefore, BM must overcome
the collected flow from the RPE. The flow resistance from BM is believed to occur mostly
through the inner collagenous layer (Starita, Hussain, Patmore, & Marshall, 1997). The BM is a
permeable membrane that allows transport of various sized molecules. Smaller molecules pass
freely across the membrane, while large molecules diffuse at a much slower rate. It has long
been believed that BM contained an exclusion limit of macromolecules of 66-200 kDa.
Recently, research has suggested this limit is much higher. While large molecules have a
difficult time diffusing through the membrane, it has been shown that molecules as large as 550
kDa have passed through the membrane (A. A. Hussain, Starita, Hodgetts, & Marshall, 2010; A.
a Hussain, Rowe, & Marshall, 2002; Moore & Clover, 2001).

While the BM is a very thin membrane, it constitutes functions that are imperative for 20
retinal homeostasis. Changes due to age include: thinning of the BM, lipoprotein accumulation,
drusen deposits (which can negatively affect attachment of the RPE) proper fluid transport from
the RPE to the choroid and prevention of essential nutrients to reach the outer retina.

Age-Related Macular Degeneration
AMD is identified as wet or dry AMD. Rather than one disease, there has been evidence
suggesting that wet and dry AMD may be two distinct diseases with different pathogeneses
(Chong et al., 2005; G. Hageman, 2001). This hypothesis is supported clinically where patients
showing signs of early AMD may go on to develop either form of advanced AMD. It has also
been reported that patients may have no symptoms of early AMD, but develop wet AMD
rapidly. Other clinicians have reported some patients being diagnosed with wet AMD in one eye
and dry AMD in the other (De Jong, 2006). Dry AMD accounts for 90% of AMD patients. It is
slow progressing and some patients may show no visual impairment. Early changes to the
diseased retina consist of nearly invisible basal laminar and basal linear deposits. Basal laminar
deposits are composed of ECM protein and collagen located between the RPE plasma and BM.
Basal linear deposits are composed of membranous material located externally of BM. The initial
clinical characterization of dry AMD is the formation of hard or soft drusen deposits at the ocular
fundus. The drusen formation is thought to occur with the combination of the basal laminar
deposits, basal linear deposits and secondary RPE changes. Hard drusen may never cause further
damage to the retina; however, soft drusen is associated with the progression of early AMD to
geographic atrophy (nonexudative AMD). The presence of soft drusen is considered a high-risk
factor for AMD. As a result, several groups have focused on examining the composition of

drusen in order to further understand the pathogenesis of AMD. These studies have revealed 21
the presence of several compliment related proteins and inflammatory factors such as the Creactive protein (Crabb, 2014; Crabb et al., 2002; G. Hageman, 2001). Proteomic studies have
led to the investigation of genetic factors as an underlying cause for AMD including the
discovery of sequence variants in complement factor H (Edwards et al., 2005; Edwards & Malek,
2007; R. J. Klein et al., 2005; Mousavi & Armstrong, 2013).
Geographic atrophy (GA) is considered an advanced form of dry AMD. Histology of a
druse and an immunofluorescence image from AMD diagnosed tissue is depicted in figure 1.10.
In addition to soft drusen deposits, GA is characterized with abnormal RPE including retinal cell
death, thinning of BM and degeneration of choriocapillaris (Binder & Falkner-Radler, 2008;
Chong et al., 2005; Coleman et al., 2008; G. Hageman, 2001; Mullins, Russell, Anderson, &
Hageman, 2000). Electron microscopy and immunochemistry has also shown evidence of
macrophages being present in GA diseased tissue and are thought to be phagocytizing pigment
and cellular debris (Cascella et al., 2014; Coleman et al., 2008; Sohn et al., 2014). These factors
support a correlation between inflammation and dry AMD. Hageman et. al. reported thinning of
the BM in association with AMD where BM gap formation was significantly more prevalent in
wet AMD diagnosed tissue (figure 1.11). These findings further support the hypothesis of AMD
being two different diseases due to the significant differences between human tissues obtained
from donors diagnosed with wet or dry AMD.
Wet AMD is also known as neovascular AMD. Wet AMD accounts for only 10% of all
AMD patients; however, it is responsible for rapid and permanent vision loss for diagnosed
patients. It is clinically diagnosed by choroidal neovascularization (CNV).
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Figure 1.10: Depiction of drusen from human fundus. Top: HE-stained histology of druse,
Bottom: Immunofluorescence image from human fundus diagnosed with AMD (Mullins et al.,
2000).

23

82 year old control donor

84 year old early AMD
diagnosed donor
83 year old wet AMD
diagnosed donor

Wet AMD=CNV
Dry AMD= GA

Figure 1.11: Decreased thickness and elasticity of BM. Top: transmission electron microscopy
image of human BM indicating gaps found within EL layer. Bottom: Graphical representation of
gap length from tissues diagnosed with disease and age matched donors (Chong et al., 2005).

CNV is clinically characterized by the leaking and growth of new blood vessels from the
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choriocapillaris into other retinal layers (Binder & Falkner-Radler, 2008; Blasiak, Petrovski,
Veréb, Facskó, & Kaarniranta, 2014; Coleman et al., 2008), and it is thought to be stimulated by
an imbalance in angiogenic vascular endothelial growth factor (VEGF) and angio-inhibitor
pigment epithelium-derived factor (PEDF). Early CNV begins beneath the RPE and eventually
breaks through to develop exudative AMD typically following the path of least resistance. The
disease can quickly progress and has been shown to cause severe physiological damages, mostly
affecting BM and RPE (Binder & Falkner-Radler, 2008; Coleman et al., 2008; Gehrs et al.,
2006). The physiological damages that accrue include: RPE tearing, hemorrhage, calcification,
fibro vascular scarring and further retinal cell loss. Patient symptoms initially begin with blurred
or distorted central vision and can progress to complete central vision loss (Binder & FalknerRadler, 2008; Coleman et al., 2008; NEI, 2016). There has been significant research indicating a
striking correlation between hearing loss, Alzheimer’s disease, cardiovascular disease and
atherosclerosis (Akpek & Smith, 2013; Cascella et al., 2014; Klaver et al., 1999; R. Klein,
Cruickshanks, Klein, Nondahl, & Wiley, 1998; Lambert et al., 2016; Ni et al., 2009).
Illustrations and retinal angiograms depicting wet AMD and dry AMD diagnosed retinas are
shown in figure 1.12.
Diabetic Retinopathy
Diabetic retinopathy (DR) is one of the leading causes for new cases in legal blindness in
the United States. An estimated 2.9 million Americans have diabetic retinopathy. DR is
classified in two forms as non-proliferative and proliferative (Akpek & Smith, 2013).
Proliferative diabetic retinopathy (PDR) is the more severe type that is accompanied with vision
loss and has been associated with wet AMD.
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Figure 1.12: Depictions of dry AMD, wet AMD and DR. (A) Angiogram of human retina
diagnosed with dry AMD, (B) Angiogram of human retina diagnosed with Wet AMD, (C)
Angiogram of human retina diagnosed with DR, (D) Illustration of dry AMD clinical symptoms,
(E) Illustration of wet AMD clinical symptoms, (F) Illustration of angiogenesis associated with
wet AMD and DR (NEI, 2016).

PDR is clinically marked by proliferation of new retinal blood vessels that can cause
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hemorrhage into the vitreous cavity and eventually lead to retinal detachment. Pathological
changes for PDR include several retinal vascular abnormalities including: impairment of retinal
blood flow, increased vascular permeability, breakdown of the blood-retinal barrier and capillary
occlusion resulting in localized hypoxia. Progression of retinal hypoxia has been shown to
induce the angiogenic factor, VEGF, which promotes retinal neovascularization (Akpek &
Smith, 2013; T. Kim et al., 2007). Additional factors associated with the pathogenesis of PDR
include: angiogenic factors like VEGF, angiotensin-converting enzyme, insulin-like growth
factor, angiopoietin, erythropoietin, placenta growth factor, and advanced glycation end products
(AGEs) (Guidry, Feist, Morris, & Hardwick, 2004; Kida et al., 2003; Matsumoto, Takahashi,
Chikuda, & Arai, 2002; Ohashi et al., 2004; Watanabe et al., 2005). It is the combination of upregulated angiogenic factors and down-regulated anti-angiogenic factors that make DR
commonly associated with wet AMD. While there seems to be a connection with wet AMD and
PDR with neovascularization, new proteomic studies and the geography of the angiogenesis
within the retina set the two diseases apart (figure 1.12). Kuiper et. al. reported a co-regulation of
VEGF and the pro-fibrotic connective tissue growth factor (CTGF) which may determine the
angio-fibrotic switch causing hemorrhage into the vitreous body (Kuiper et al., 2008).
Cell Death Mechanisms
There are several mechanisms of cell death that have been studied; few have been
associated with RPE cell death. One of the most widely studied is apoptosis, an ATP-dependent
and irreversible type of cell death. Apoptosis is a programed cell death mediated by a cascade of
caspase activation and is characterized by chromatin condensation, membrane protrusion and

cellular shrinkage (Paoli, Giannoni, & Chiarugi, 2013; Teng et al., 2005; Vandenabeele,
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Declercq, & Vanden Berghe, 2008; Wazir et al., 2015). Apoptosis is initiated in response to
irreparable damage to DNA or induced by inflammatory cells. There have been two pathways of
apoptosis that have been identified: intrinsic and extrinsic. Inflammatory cells, typically in
response to oncogenesis or systemic infection, induce the extrinsic pathway. The death domain
of death receptors, which are a part of the family of tumor necrosis factor receptors, interact with
adapter proteins initiating intracellular pathways. The intrinsic pathway has been shown to be
influenced by non-receptor factors. These include toxins, endoplasmic reticulum stress and free
radicals. Pro-apoptotic protein Bak and Bax translocate from the cytosol to the outer
mitochondrial membrane (OMM). Changes in OMM cause permeabilization and subsequently
triggers the release of cytochrome c. (Paoli et al., 2013; Wazir et al., 2015). Figure 1.13 displays
a schematic of the two apoptosis pathways. Anoikis is a specialized form of apoptosis that
involves both of these pathways. It is a term coined for the initiation of apoptosis due to the
detachment of epithelial cells from the extracellular matrix. Anoikis is hypothesized to be
triggered in order to preserve normal tissue structure from inappropriate epithelial cell
proliferation and migration. The pathway is thought to involve the activation or overexpression
of integrin signaling molecules (Dobler, Ahmed, Song, Eboigbodin, & Thornalley, 2006;
Gilmore, 2005; Paoli et al., 2013; Wazir et al., 2015). The majority of research done regarding
Anoikis has been in connection to oncogenesis; however, given the characteristics of the
pathway, it can be hypothesized that RPE cell death may undergo Anoikis when BM is stressed.
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Figure 1.13: Depiction of extrinsic and intrinsic apoptosis biochemical pathways (Paoli et al.,
2013).

Another type of cell death is autophagic cell death (ACD). ACD is characterized by
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morphological changes to the cell where autophagic vacuoles within the cytoplasm of a dying
cell are observed by microscopy (Kroemer & Levine, 2008; Vandenabeele et al., 2008). ACD
differs from apoptosis due to the absence of chromatin condensation. Previous studies have
depicted autophagy as a “clean-up” event that occurs in order to clear dying cells. Recently,
studies have suggested autophagy is not only a pro-survival mechanism, but also a way for dying
cells to harvest the energy required for proper signaling for cell removal by extracellular
phagocytes. It is still in question if autophagy occurs as a downstream mechanism within a cell
death pathway, such as apoptosis or necrosis, or is a sole perpetrator of cell death. There is
emerging evidence in literature to support both arguments (Kroemer & Levine, 2008).
Necrosis is a cell death pathway that has also been widely studied. Necrotic cell death is
reversible in its early stages and is characterized by mitochondrial impairment and cell swelling
followed by cell lyses. When the cell membrane ruptures, subsequent release of the cell contents
induce an inflammatory response (Linkermann & Green, 2014; Teng et al., 2005; Vandenabeele
et al., 2008). Necrosis has been shown to be especially difficult to target due to the pathway
being a nonregulated response to overwhelming stress. However, recent research has suggested
a portion of necrosis may be regulated by cellular machinery. This portion of necrosis has been
termed necroptosis (Degterev et al., 2005). Necroptosis is considered to be a type of
programmed necrosis dependent upon receptor interacting protein kinase 1 and 3 (RIPK1/3)
(Kaczmarek, Vandenabeele, & Krysko, 2013; Linkermann & Green, 2014; W. Zhou & Yuan,
2014). It has been recently associated with several inflammatory diseases including
inflammatory bowel disease, stroke and atherosclerosis (Linkermann & Green, 2014; W. Zhou &
Yuan, 2014).

Pyroptosis is a newly emerged pro-inflammatory type of programed cell death. It
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differs from apoptosis as it is specifically dependent upon caspase-1 activation where apoptosis
is dependent on caspase-3 activation (Doitsh et al., 2014; Hanus et al., 2013). Caspase-1 is
activated through an assembly of the inflammasome that facilitates the cleavage of procaspase-1.
Upon caspase-1 activation, dying cells release their cytoplasmic contents into the extracellular
space (Doitsh et al., 2014; L. A. Kim et al., 2014).

Lipofuscin
One major risk factor of retinal disease is the build-up of lipofuscin. While the
accumulation of lipofuscin is a common sign of cellular aging, it is the increased accumulation of
lipofuscin in the retinal pigment epithelium (RPE) that is related to photoreceptor cell death and
is thought to be one of the leading causes of AMD (figure 1.14). Human retinal lipofuscin is a
brown-yellow pigment that is auto-fluorescent and composed of a highly complex mixture of
lipids, proteins, vision cycle byproducts and oxidized polyunsaturated fatty acids not reported in
any database (Biesemeier, Schraermeyer, & Eibl, 2011; Murdaugh et al., 2011; Murdaugh,
Wang, Del Priore, Dillon, & Gaillard, 2010; Ng et al., 2008). The RPE cytoplasmic volume of
lipofuscin has been found to be significantly greater in the macula rather than in the periphery (C
Kathleen Dorey, Garsd, & J, 1989). This greatly implicates the macular accumulation of
lipofuscin as a potential cause or risk factor for macular dystrophies. The accumulation of
lipofuscin is not only associated with AMD, but also Best’s macular dystrophy and Stargardt’s
disease (Biesemeier et al., 2011). There has been some progress identifying components of
lipofuscin, including retinoid products, oxidative lipid products, protein degradation products,
inflammatory markers and fluorophores.
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Figure 1.14: Illustration of RPE cell in a young person (left) compared to an elderly person
(right) (De Jong, 2006).

However, because of the heterogeneous nature of lipofuscin the composition of the retinal
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accumulation continues to be an active area of study.
Photoreceptor outer segments (POS) are digested in the RPE cell lysosomes. The RPE
lysosomes contain several lytic enzymes believed to be responsible for the incredibly efficient
process of POS digestion. These enzymes include: cathepsin D, cathepsin B, α-mannosidase, Nacetyl-β-D-glucosaminidase, acid lipase, acid phosphatase, α -fructosidase, α -galactosidase, α glucosidase, β -galactosidase, β -glucosidase, β -glucuronidase and phospholipases A1 and A1
(Kennedy et al., 1995). The retina is the most oxygen-consuming tissue in the human body where
most of the oxygen consumption occurs in the photoreceptors. Thus, the photoreceptors are a
sight where oxidative and photo oxidative damage is likely to occur (Mazzitello, Arizmendi,
Family, & Grossniklaus, 2009). Lipofuscin accumulation is thought to occur by either alteration
in the ROS or alteration in the RPE cell. One method is that the ROS may be oxidatively
damaged prior to RPE phagocytosis where the enzymes in the lysosome are incapable of
properly digesting the altered POS segments (Kennedy et al., 1995). The second is by a
dysfunctional RPE cell where primary failure of the phagocytic functions and autophagy
functions of the RPE may lead to an accumulation of ROS residues that can undergo further
modifications to form lipofuscin (see figure 1.7) (Boulton, 2014; Kennedy et al., 1995;
Mazzitello et al., 2009).
Lipofuscin has been shown to contain fluorophores that emit green to orange
wavelengths. Figure 1.15 depicts the auto-fluorescent characteristics of RPE lipofuscin. Nretinylidene-N-retinylethanolamine (A2E) has been detected in human retinal lipofuscin and is
thought to contribute to the longer wavelengths observed. A2E synthesis has been proposed to
occur by the phosphate hydrolysis of the precursor N-retinylidene-N-

retinylphosphatidylethanolamine (A2-PE) (figure 1.16). A2-PE is believed to form as a by-
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product of a dysfunctional visual cycle. Its biological synthesis begins when all-trans retinal
reacts with phosphatidylethanolamine (PE) instead of being reduced. A Schiff base conjugate is
thought to serve as a substrate for this reaction.

Figure 1.15: RPE comparison depicting autofluorescence granules of lipofuscin in older RPE
(right) using epifluorescence with FITC filter (ex: 495 nm/em: 519 nm) (Gu et al., 2012).
The product, N-retinylidene-PE, is then transported from the photoreceptors to the RPE
where a hydrolysis reaction occurs with a second all-trans retinal molecule; thereby,
synthesizing A2-PE. In the RPE, A2-PE is digested by phospholipase D where the phospholipid
portion of PE is cleaved to form A2E (Ben-Shabat et al., 2002; Jianghua Liu, Itagaki, BenShabat, Nakanishi, & Sparrow, 2000; Mata, Weng, & Travis, 2000; Parish, Hashimoto,
Nakanishi, Dillon, & Sparrow, 1998). Furthermore, light exposure is believed to cause the
isomerization of A2E into iso-A2E (Fishkin, Jang, Itagaki, Sparrow, & Nakanishi, 2003; Parish
et al., 1998; Janet R. Sparrow et al., 2003). This process strictly depends on the photo activation
of rhodopsin. Recently, a second pathway has been suggested where A2E and lipofuscin
accumulation can occur in dark conditions. In the dark, it is suggested that 11-cis retinal serves
as the precursor to A2E (Boyer et al., 2012).
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Figure 1.16: The proposed biological synthesis of A2E initiated by the all-trans retinal (ATR)
and phosphatidylethanolamine (PE) reaction.

Figure 1.17 illustrates the proposed biological synthesis of A2E. While recent studies indicate 35
A2E may not be as predominate in the macula as previously thought (Ablonczy et al., 2013;
Tang et al., 2013), the oxidation and photooxidation of A2E has been associated with oxidative
stress correlating to AMD progression (Gaillard et al., 2004; Murdaugh et al., 2010; Z. Wang,
Keller, Dillon, & Gaillard, 2006).

A2E Induced Oxidative Stress and AMD
Oxidative stress is known to occur when there is an imbalance of reactive oxygen species
(ROS) and the biological system’s ability to counteract by detoxifying. A2E has been shown to
act as a photosensitive generator of singlet oxygen and superoxide that could cause RPE damage
(Janet R. Sparrow, Nakanishi, & Parish, 2000; Wu, Yanase, Feng, Siegel, & Sparrow, 2010).
Several studies have shown the photooxidative properties A2E possesses. Oxidation of A2E has
been shown to readily occur in the retina and evidence of continuous oxidation of the molecule
has been associated with RPE lipofuscin (Avalle, Wang, Dillon, & Gaillard, 2004; James Dillon
et al., 2004). A2E is known to strongly absorb in the blue region of the visible spectrum with a
λm=430 nm, and research has demonstrated the RPE has particular susceptibility to blue light
damage in the aging eye (J. Dillon, Wang, Avalle, & Gaillard, 2004; Gaillard et al., 2004; Janet
R. Sparrow et al., 2000; Z. Wang et al., 2006).
Blue light irradiation of A2E has been shown to form highly reactive oxidative species.
Figure 1.18 displays where the molecule is photooxidized and the mass of the corresponding
aldehyde that is formed. Studies have shown that these species readily modify BM proteins
fibronectin and laminin preferentially at arginine and lysine residues (Murdaugh, Dillon, &
Gaillard, 2009; M. T. Thao, Renfus, Dillon, & Gaillard, 2014).
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Figure 1.17: Pathways of lipofuscin and A2E formation (Boyer et al., 2012).
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Figure 1.18: Structures of A2E and oxidized A2E with proposed aldehyde formation. Each
dashed line represents where the molecule photooxidizes with the mass of the subsequent
aldehyde (Z. Wang et al., 2006).

Modification of these BM proteins can substantially affect the integrity of the RPE and
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consequently disrupt the visual cycle. Several groups have investigated the effects of blue light
irradiated A2E in association with RPE. These results have indicated apoptosis is induced as a
consequence causing RPE cell death (J. R. Sparrow & Cai, 2001; Janet R. Sparrow et al., 2000).
Additionally, Feng et. al, showed ROS accumulation can disturb RPE endoplasmic reticulum
(ER) homeostasis where two ER stress markers were noted to be unregulated with irradiated
A2E containing cells (Feng & Sun, 2014). Oxidized A2E and photooxidized A2E products have
a strong correlation to visual cycle disruption; thereby, being implicated in AMD onset and
progression.
Inflammation and AMD
Inflammation is the body’s response to foreign substances and is triggered in order to
limit tissue damage and remove the pathogenic invasion. During the process of inflammation,
phagocytes secrete chemically reactive oxidants, radicals and electrophilic compounds.
Nitric oxide (NO) is a radical that is produced and plays a major role in the inflammation
response. Depending on the local concentration of NO, the inflammation process can be either
protective or detrimental to biological systems. The up-regulation of NO has been correlated
with chronic inflammation and been shown to cause mitochondrial respiratory enzyme inhibition
(Evereklioglu et al., 2003; Paik, Dillon, Galicia, & Tilson, 2001). Chronic inflammation has been
extensively studied as a contributing factor to several diseases including cardiovascular disease,
cancer, rheumatoid arthritis, diabetes and AMD.
NO is produced enzymatically by inducible nitric oxide synthase (iNOS). Induction of
iNOS expression is believed to involve the activation of several signal transduction pathways
(figure 1.19).
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Figure 1.19: Schematic iNOS expression pathways induced by LPS from macrophage.

Lipopolysaccharide (LPS), present in macrophages, is one stimuli believed to initiate the
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induction of iNOS. LPS is thought to activate mitogen activated protein kinase (MAPK),
inflammatory cytokines such as IFN-β and transcription agent nuclear factor sites, specifically
nF-κB. MAPK is composed of three principal family members: extracellular signal-regulated
kinase (ERK), c-Jun NH2-terminal kinases (JNKs) and p38. Each is activated through
phosphorylation of threonine and tyrosine residues by either MAPK kinases (MKK) or
MAPK/ERK kinases. Inflammatory cytokines have been shown to be essential in activating
tyrosine kinase and Janus tyrosine kinase. These tyrosine kinases activate the signal transducers
and activators of transcription (STAT) (Chan et al., 2012; H. J. Kim et al., 2007). With the
appropriate mix of cytokines and kinases, iNOS can be activated in many types of cells other
than macrophages with other stimuli.
It has been measured that in stimulated macrophages, iNOS can produce up to 4 x 106
molecules of NO per cell. NO is primarily produced as a cytotoxic agent in response to
pathogenic species along with several other molecules including: super oxides (O2-), hydrogen
peroxide (H2O2), FAS ligand, tumor necrosis factor and inflammatory cytokines (figure 1.20). In
regions of chronic inflammation, NO concentration can be very high which allow for further
reactions to occur producing highly reactive species. NO and O2- can further react to form the
very reactive and long-lived peroxynitrite molecule (ONOO-), which can degrade into NO3- and
NO2- ions. Exogenous sources of nitrite exposure include life style choices such as cigarette
smoking. The molecules ONOO- and NO2- have been linked to non-enzymatic nitration and
mammalian cell death (Dedon & Tannenbaum, 2004).
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Figure 1.20: The generated reactive species released from iNOS expression (Dedon &
Tannenbaum, 2004).

Nitrite ion has been shown to play a role in non-enzymatic nitration of collagen-
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containing tissues and to react with free amino acids, such as tyrosine, within the extra cellular
matrix of RPE cells (Paik et al., 2001; Z. Wang, Paik, Dillon, & Gaillard, 2007). Studies have
also shown the nitrite ion can react with the molecule A2E to form nitro-A2E (Murdaugh et al.,
2010). Additionally, NO has been shown to have increased concentration in plasma obtained
from patients diagnosed with AMD (Evereklioglu et al., 2003). These findings further suggest
chronic inflammation may be an underlying factor for the pathogenesis of AMD.

Advanced Glycation End Products and AMD
In addition to the oxidative stress of lipofuscin and the photooxidation of A2E, advanced
glycation end products (AGEs) are also thought to cause oxidative stress upon the retina. One of
the largest risk factors for AMD is aging. AGEs are mixtures of proteins that have been glycated
and oxidized after exposure to reactive aldehydes such as glucose, methylglyoxal and glyoxal.
Studies have shown that AGEs advance the progression of age-associated disease by endocytotic
uptake and degradation, induction of cytokines and growth factors (Nagai et al., 2000; Vlassara,
Bucala, & Striker, 1994). These biological responses have been linked to the impairment of
structure and function of essential proteins. AGE modifications have been shown to be involved
in several age-related diseases, including atherosclerosis, diabetes, renal disease and aged skin.
The characterization of AGE formation and accumulation include fluorescent, brown
color change and intra- or intermolecular cross-linking. AGE formation is known to occur by a
Maillard reaction. The Maillard reaction involves several reactive intermediates that are formed
by enolization, dehydration, cyclization, fragmentation and oxidation reactions. Specifically, an
aldehyde group from reducing sugars undergoes non-enzymatic condensation with the amino

group of proteins, producing a Schiff base. The Schiff base rearranges to form an Amadori
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product or undergoes a reaction to yield Schiff’s base adduct of glycolaldehyde with amine. The
Glycolaldhehyde-alkylimine product can then be hydrolyzed to release glycolaldehyde or it can
rearrange to form an aldoamine (Glomb & Monnier, 1995; Namiki & Hayashi, 1975). The
aldoamine can be converted into a glyoxal adduct which can then react to produce AGEs. The
Amadori product can be cleaved to form reactive AGE intermediates, such as methylglyoxal that
react with protein residues (Glomb & Monnier, 1995). Additionally, AGEs can form by the
autoxidation of D-glucose (Wells-Knecht, Zyzak, Litchfield, Thorpe, & Baynes, 1995). These
reactions are summed up in figure 1.21. AGEs formed include the following: N(Carboxymethyl) lysine (CML), glyoxal-lysine dimer (GOLD), methylglyoxal-lysine dimer
(MOLD), imidazolone and pentosidine.
AGE modification to the BM have been identified, particularly collagen cross-linking
adducts such as glycolaldehyde. AGEs such as CML, CEL and pentosidine have been
extensively studied as BM modifications and are linked to RPE detachment and cell death
(Duran-Jimenez et al., 2009; Glenn et al., 2009; Handa et al., 2016; Karachalias, Babaei-Jadidi,
Ahmed, & Thornalley, 2003; Nagai et al., 2000; Sell & Monnir, 1989). Studies of drusen have
also revealed AGE modification accumulation in the BM (Crabb, 2014; Crabb et al., 2002). A
proteomic study conducted by Schutt et. al. detected AGE modified proteins in RPE lipofuscin
(Schutt, Bergmann, Holz, & Kopitz, 2003).
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Figure 1.21: AGE formation from D-glucose, Schiff base and Amadori product (Wells-Knecht et
al., 1995)
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Dissertation Research
AMD is the leading cause of blindness in developed countries and diagnoses are expected
to increase dramatically over the next several decades. There are several risk factors for the
disease including oxidative stress, increased lipofuscin build-up, inflammation, race, aging and
genetic factors; however, the pathogenesis for the disease is still unknown. Therefore, this
dissertation work aims to understand the pathogenesis of AMD by understanding the cellular
effects of ECM modifications and lipofuscin accumulations.
Retinal lipofuscin accumulation has been shown to increase in tissue diagnosed with
AMD. Further elucidation of molecules found in human retinal lipofuscin is essential to
understanding the origin of lipofuscin build-up. This research investigates lipofuscin extracted
from human RPE cells that have been diagnosed with retinal disease and compared to agematched donors. Understanding the molecular composition of lipofuscin extracted from donor
tissue where the donors have previously been diagnosed with wet AMD, dry AMD or diabetic
retinopathy, can shed light on the pathogenesis of retinal disease. This study focuses on smaller
molecular weight entities of human retinal lipofuscin that can serve as biomarkers for disease.
These include products of photooxidized A2E, A2E protein modifications, inflammatory
biomarkers and the presence of AGEs. A goal of this dissertation work is to further understand
the biological and chemical retinal changes found in tissue obtained from donors previously
diagnosed with either wet or dry AMD. These results not only have the potential to improve
diagnostic techniques, but can also elucidate the pathway of disease onset and progression. An

understanding of the pathway can allow for better treatment options and possibly enhanced
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prevention of the disease.
This dissertation will provide a better understanding of AMD, specifically the effects of
chemical changes during aging. Cellular models are used in conjunction with human tissue
samples to answer questions concerning the impact of biological changes induced by chemical
processes on the aging retina.
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CHAPTER 2
MATERIALS AND METHODS
Materials
The cell line used in the current study, ARPE-19 (ATTC® CRL-2302), was purchased
from American Type Culture Collection (ATCC®, Manassas, VA, USA). ATCC® runs
rigorous verification studies on all cultures to ensure validity of the cell line purchased. The
ARPE-19 cell line used was authenticated through GRFC DNA Services (John Hopkins
University, Baltimore, MD, USA). Dulbecco’s Modified Eagles Medium (DMEM), 3-(4,5dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT), US origin qualified fetal bovine
serum (FBS), L-glutamine, glycine, sodium chloride, acetic acid, sodium acetate trihydrate,
sodium nitrite, potassium chloride, sodium phosphate dibasic anhydrous, potassium phosphate
monobasic, all-trans-retinal, ethanolamine, Necrostatin-1 (non-apoptotic cell death inhibitor), ZVAD-FMK (caspase-1 inhibitor), L-α phosphatidylcholine (egg yolk; ≥ 40%), cholesterol (≥ 99
%), liquid bromine (99.5%, ACS reagent), sodium acetate, uranyl acetate, glacial acetic acid,
tert-butyl-methyl ether, fluorescein (FITC, ≥ 99%), Rose Bengal (95%), Rhodamine 123 (≥
85%), TWEEN® 20, Millipore C-18 Zip Tip® pipette tips, sodium cholesterol sulfate (≥ 98%), LValine, L-Leucine, L-Phenylalanine, L-Tryptophan, L-Cysteine, L-Tyrosine, L-Arginine, LLysine and HPLC grade chloroform were purchased from Sigma-Aldrich (St. Louis, MO, USA).
HPLC grade methanol (MeOH), dimethyl sulfoxide (DMSO), TrypLE, glycolaldehyde, glass

microscope slides, glass cover slips and Hyclone antibiotic antimycotic solution were
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purchased from Thermo Fisher Scientific (Pittsburg, PA, USA). Ethanol (100%) was purchased
from Ultrapure (Darien, CT, USA). FITC Annexin V Apoptosis Detection Kit I and Z-DEVDFMK (caspase-3 inhibitor) and human fibronectin (FN) protein were purchased from BD
Biosciences (San Jose, CA, USA). All water used was purified using a Millipore Milli-Q Plus
Purepak 2 water purification system (Bellerica, MA, USA) with a resistivity of 18.2 MΩcm at
25°C. All solutions made for cell studies were purified using 0.2-µm filters either by syringe
filtration or vacuum filtration. All 0.2 µm filters were purchased through Thermo Fisher
Scientific (Pittsburg, PA, USA).

Instrumentation
The fluorescence spectra of fibronectin modifications were obtained with a Hitachi F2500 Fluorescence Spectrophotometer (Dallas, TX, USA). All UV/Vis data were collected on an
Ocean Optics S2000 Spectrometer (Dunedin, FL, USA). For MTT assays, the 24 well plate
absorbance was read with a BioTek Synergy 2 plate reader (Winooski, VT, USA). Synthesized
A2E was purified using a Hypersil C18 (250 x 4.6 mm) column (Thermo Scientific, Pittsburg,
PA, USA) on a Varian ProStar HPLC coupled to a Varian ProStar 320 UV/VIS Detector
(Agilent Technologies, Santa Clara, CA, USA). All blue light irradiation was performed in a
blue-light chamber consisting of two Phillips “Special Blue” bilirubin bulbs filtered with a onequarter-inch piece of Plexiglas. The Phillips blue bulbs produce mostly blue light from 420-480
nm; however, a small line of 360 nm wavelength of UV light is emitted as well. The Plexiglas
filters out this UV light. The chamber is protected from outside light with blackout fabric.

Microscopy
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Microscopy was used as an essential tool for various projects within this work. Confocal
microscopy was performed using a Zeiss LSM 5 Pascal Confocal Laser Scanning Microscope
equipped with Zeiss Pascal LSM 5 image acquisition and optimization software (Thornwood,
NY, USA). The general confocal principle allows for a reduction in out-of-focus light, and a
reduction in fluorescent degradation. In general, fluorescent light is focused on the specimen
with a collimator. The fluorescent light accrues from an argon laser exciting the fluorophore in
the sample. Scanning mirrors are used to pass the focused light onto the specimen and scan the
sample (Fine, 2005; M. Thao, 2014). A general schematic is shown in figure 2.1.

Flow Cytometry
The viability of ARPE-19 cells was analyzed using a FACSCalibur flow cytometer (BD
Biosciences, San Jose, CA, USA). Flow cytometry is the measurement of cells in a flow system
(Ormerod, 1999). In short, the technique involves a suspension of stained cells injected into the
instrument and are made to flow in a single file, through hydrodynamic focusing with a sheath of
phosphate buffered saline, where light is focused onto the cells and their fluorescence recorded
(Grogan & Collins, 1990; Ormerod, 1999). Figure 2.2 shows a general hydrodynamic focusing
flow cytometer set up. The BD FACSCalibur system allows for analysis of multiple
fluorochromes within one suspension to then sort cells in subset populations based on the
fluorescence reading. The FACSCalibur flow cytometer consists of a dual laser design, an aircooled argon laser and a red diode laser, giving a better sensitivity for multiple fluorochrome
analysis (“BD FACSCalibur,” 2009).
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Figure 2.1: Basic Principles of a confocal microscope (M. Thao, 2014).
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Figure 2.2: General hydrodynamic focusing flow cytometer depiction. This shows the single file
line the cells are focused in for individual reading with subsequent fluorescence and/or scattered
light signals (Abcam, 1998).

The optical configuration and the optical bench set up are shown in figures 2.3 and 2.4. Cells 52
are sorted based off of the fluorescence that is transmitted (Grogan & Collins, 1990; Ormerod,
1999). When a cell has intersected a specific laser beam, the light that is transmitted is
composed of scattered and fluorescent light. The fluorescent and/or scattered light signals
produced are collected by lenses and focused onto photomultiplier detectors where the signal is
amplified, measured, sent to be displayed on a screen and stored for further analysis (“BD
FACSCalibur,” 2009; Grogan & Collins, 1990). Figure 2.5 is a cartoon depiction of the BD
FACSCalibur flow cytometry system from injection to selection. The sorting occurs under a
completely enclosed and aerosol-free environment to reduce side scattering and increase safety
precautions (“BD FACSCalibur,” 2009). Further analysis is performed using FlowJo software
(FlowJo, LLC).
Mass Spectrometry
Lipofuscin samples were analyzed using either Surveyor high performance liquid
chromatography (HPLC) coupled to a Surveyor photo diode array (PDA) and Thermo Finnigan
LCQ Advantage mass spectrometer (MS) (San Jose, CA, USA), or an Agilent HPLC coupled
with an Agilent PDA (Santa Clara, CA, USA) and Thermo Fisher Scientific Q-Exactive MS
(Waltham, MA). Both mass spectrometers were equipped with an electrospray ionization (ESI)
source. Synthesized A2E, synthesized A2E + amino acids and synthesized nitro-A2E samples
were all analyzed using ESI-MS/MS with the LCQ Advantage mass spectrometer, Xcalibur
Software and Qualbrowser (Thermo Scientific, San Jose, CA, USA).
ESI is a common and highly adequate technique for liquid samples used in mass
spectrometry. In general, ESI is a process that uses an electric field to produce a fine spray of
charged droplets.

53

Figure 2.3: BD FACSCalibur optical path configuration (“BD FACSCalibur,” 2009)
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Figure 2.4: BD FACSCalibur optical bench top view (“BD FACSCalibur,” 2009).
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Figure 2.5: BD FACSCalibur sorting mechanism from sample injection to sample collection
(“BD FACSCalibur,” 2009).

The method involves the sample to be injected into either a sample loop or pumped via a
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syringe into capillary tubing in a controlled, continuous flow. A depiction of the ESI interface is
shown in figure 2.6. The electric field produced is due to the potential difference between the
counter-electrode (the walls surrounding the atmospheric pressure region) and the capillary tip
held at a high voltage of 2-5 kV. For positive-ion mode mass spectrometry, samples contain at
least a 0.1% acid (typically acetic acid or formic acid) to protonate the analytes. The positively
charged molecules migrate towards the counter electrode and the accumulation is
counterbalanced by the surface tension of the liquid. This electrochemical process allows the
formation of a Taylor cone. When the applied electric force is strong enough, a stream of liquid
breaks from the Taylor cone. Evaporation of the charged particles formed from the electrostatic
field is assisted with a constant flow of nitrogen gas. The charged droplets decrease in size as
evaporation occurs until reaching their Rayleigh limit where Coulombic explosion occurs
continually decreasing the size of the droplets until the droplet decreases to a point where only
the analyte ions of interest are left. The charged molecule is then dispersed into the ambient gas.
Figure 2.7 shows the mechanism of ion formation. The charged molecule is then carried to the
mass analyzer (Dass, 2007b; Murdaugh, 2010; M. Thao, 2014).
The LCQ Advantage mass spectrometer used is a quadrupole ion trap (QIT). A QIT
consists of a three-electrode structure: a central ring and two identical end-caps with hyperbolic
geometry (figure 2.8). Mass separation in a QIT occurs by first sorting the ions in the trapping
space. An oscillating electric field, created within the three-electrode structure, manipulates the
ions motion in time. The applied radio frequency field can be changed to eject the ions from the
trapping space in sequence based on their trajectories in the oscillating field (Dass, 2007a; Glish
& Vachet, 2003; Murdaugh, 2010; M. Thao, 2014).
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Figure 2.6: Schematic of Electrospray Ionization interface (Bull, 2005).
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Figure 2.7: Schematic view of ion formation using ESI, including the Taylor cone, Rayleigh
limit and Coulombic explosion (Bull, 2005).
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Figure 2.8: Quadrupole ion trap schematic (Glish & Vachet, 2003).

The ions are then carried to the secondary-electron multiplier (SEM) that serves as the ion
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detector in the LCQ Advantage. The SEM amplifies the signal of the incoming ion beam due to
a series of dynodes with conducting surfaces that act as an array of descending positive potential
electrodes. Each dynode the fast-moving ions strike, several secondary electrons are emitted.
This continues as the beam moves through the SEM. Figure 2.9 shows a general SEM where it
can be visualized that with each emitted electron reflected the current is amplified. Eventually,
the secondary electrons resulting from each surface-striking electron are collected at the end of
the electron multiplier at a second electrode known as the anode (Dass, 2007a; Murdaugh, 2010;
M. Thao, 2014). The signal is then recorded, displayed and analyzed using Thermo Fisher
Xcalibur, Qualbrowser and Scripps Research Institute XCMS software.
The Q-Exactive mass spectrometer used is a hybrid quadrupole-Orbitrap located at the
Proteomics Center of Excellence at Northwestern University (Evanston, IL, USA). After
ionization, the ions will travel first to the quadrupole where four parallel metal rods act as
electrodes. Applying direct-current (positive) and radio frequency (negative) potentials to these
electrodes create a high-frequency oscillating electric field. Mass separation can be obtained by
the stable vibratory motion of ions created by this electric field (Dass, 2007a). Molecules with
small mass-to-charge ratios will be accelerated to the highest velocities causing them to be
eliminated from the field-defining space. Ions with a higher mass-to-charge ratio will remain
confined within the boundaries of the rods. Because of the positive and negative relationship of
the rods, the negative rods can act as a low-pass filter that will allow a stability window for ions
of a narrow mass-to-charge ratio to pass through the rods. An Orbitrap mass analyzer allows
ions to be injected at high energies and orbit around a central electrode due to a small
electrostatic device.
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Figure 2.9: General principle of a secondary-electron multiplier (Dass, 2007a).

Specifically, the Q-Exactive is a filter trap where the mass selection occurs in space,
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(compared to the QITs selection “in time”) where the mass-to-charge ratio values of the trapped
ions are directly related to the frequencies of their harmonic oscillations caused by the rotations
along the mass analyzers length. The ions of specified mass-to-charge range that have stable
trajectories are transferred to either storage or fragmentation allowing for high-resolution
analysis. By hybridizing the quadrupole and Orbitrap, a fast time scale selection at high
resolution can be made for fragmentation, which is particularly advantageous for biological
samples (Dass, 2007a; Eliuk & Makarov, 2015; Michalski et al., 2011). Figure 2.10 shows an
example of a quadrupole and a Q-Exactive Orbitrap mass analyzer separately. The Q-Exactive
Hybrid Quadrupole-Orbitrap places the mass selective quadrupole analyzer between the ion
source and the C-trap, a curved linear trap for ion injection, where the quadrupole acts as a mass
filter and the Orbitrap as a mass analyzer (Dass, 2007a; Michalski et al., 2011). Figure 2.11
shows a schematic of the Q-Exactive hybrid quadrupole-orbitrap set up.
The mass spectrometers used in this work are both capable of tandem mass spectrometry.
Tandem mass spectrometry is a process in which the ion of a particular mass-to-charge ratio is
selected as a parent ion to be further fragmented. The parent ion is selected, either by manual
selection in the method created by the user, or by the intensity of the ion. The LCQ Advantage
MS has the capability of collision-induced dissociation (CID) in order to fragment the parent ion.
The process of CID involves the precursor ion to be excited causing collisions with the inert
background gas (helium for the LCQ Advantage). These collisions occur in time and cause the
parent ion to fragment into smaller daughter ions. The daughter ions are, in turn, stored and
scanned out of the mass analyzer to produce a mass spectrum (MSMS), which can be used to
determine the structure of the parent ion.
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Figure 2.10: A) Schematic of an Orbitrap mass analyzer with C-trap (Eliuk & Makarov, 2015).
(B) Schematic of a quadrupole mass analyzer (Gates, 2002).
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Figure 2.11: Construction details of the Q-Exactive Hybrid set up (Michalski et al., 2011).

The Q-Exactive MS uses a fragmentation technique known as higher-energy
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collisional dissociation (HCD). This is a technique specific to the Orbitrap and occurs in space
rather than in time. Given that the fragmentation occurs in space, the mass selection,
fragmentation and mass analysis occurs in three discrete regions as depicted in figure 2.12.
From figure 2.11 and 2.12 it can be observed that the fragments are collected from the HCD in
the C-trap where the ions are then injected into the analyzer where a MSMS spectrum can be
obtained and viewed.

Methods
ARPE-19 Cell Culture
ARPE-19 cells were cultured and propagated in DMEM supplemented with 10% FBS,
1.1% L-glutamine and 1.1% antibiotic antimycotic solution using T-25 cell culture plates.
Phosphate buffered saline (10.0 mM, pH 7.4) was made using sodium chloride (137.0 mM),
potassium chloride (3.0 mM), sodium phosphate dibasic anhydrous (8.0 mM) and potassium
phosphate monobasic (92.0 mM) salts and sterilized by autoclave or vacuum filtration using 0.2µm filters. The cells were incubated in a humidified atmosphere at 37°C and 5% CO2. The
culture media was changed every 3 days and cells were passaged every 7 days or when
confluent. Cultures were examined under a light microscope to monitor confluency and healthy
growth (figure 2.13). In all experiments, cells were used between passages 5-20.
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Figure 2.12: A) CID schematic for LCQ-Advantage MS as an “in time” mass analyzer system.
(B) Sequence of events for Q-Exactive MS as an “in space” mass analyzer system.
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Figure 2.13: Micrograph of ARPE-19 cells growing health and near confluent. Image was taken
using a light microscope and magnified at 200 X.

A2E Synthesis
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A2E was synthesized using all-trans-retinal and ethanolamine as previously described
(Parish et al., 1998; M. T. Thao et al., 2014). The mixture was protected from light for the
entirety of the reaction. The reaction mixture was purified by high performance liquid
chromatography (HPLC) coupled with UV/Vis Detector (Varian Prostar HPLC and 320 UV/Vis
Detector, Agilent Technologies, Santa Clara, CA, USA with a Hypersil C18, 250 x 4.6 mm
column, Thermo-Fisher Scientific, Pittsburg, PA, USA). The gradient was as previously
described using 80:20 MeOH:H2O for 10 minutes, 100 % MeOH for 60 minutes with a flow rate
of 1.0 mL/min (M. T. Thao et al., 2014). Mass Spectrometry (MS) and tandem mass
spectrometry (Thermo Finnigan LCQ Advantage MS, San Jose, CA, USA) was used to verify
the identification of pure A2E. The concentration used in this study was determined by using
UV/Vis spectroscopy (Ocean Optics S2000 diode array spectrometer, Dunedin, FL, USA) at
λ=430 nm using an extinction coefficient of 36900 M-1cm-1 (Parish et al., 1998). Figures 2.14
and 2.15 display a representative mass spectrum and the MSMS spectrum for the synthesized
and purified A2E used in this work.

Nitration Reaction Fibronectin Modification
The fibronectin (FN) was modified one of three ways, each with its own control. To
nitrate the FN, 200 mM NaNO2 in 10mM acetate buffer at pH 5.0 was used. An amount of 100
µL of 1.0 mg/ml FN solution was added to 1400 µL NaNO2 solution and allowed to react in the
dark at 37°C for 7 days. Absorbance was taken at 350 nm to verify FN was nitrated. The
control used for this modification was 10 mM acetate buffer at pH 5.0.
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Figure 2.14: Mass spectrum of synthesized A2E in an 18 µM concentration.
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Figure 2.15: MSMS spectrum of parent ion m/z 592.5 (A2E) with corresponding molecule with
daughter m/z highlighted.

Glycation Reaction Fibronectin Modification
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FN was glycated using 50 mM glycolaldehyde in phosphate buffered serum at pH 7.4.
An amount of 100 µL of 1.0 mg/mL FN solution was added to 1400 µL of 50 mM
glycolaldehyde solution and allowed to react, in the dark at 37°C, for 84 hours. The fluorescence
was taken at an excitation wavelength 325 nm to ensure glycation of protein. The control used
for this modification was 100 µL of 1.0 mg/mL FN in phosphate buffer serum at pH 7.4.

A2E Dark and Blue Light Irradiated Reactions Fibronectin Modification
The last FN modification was done using synthetic A2E in a concentration of 18 µM. An
amount of 200 µL of 1.0 mg/mL FN solution was added to 2800 µL of 18 µM A2E. The amount
was split directly in half. The first half was blue light irradiated using a Phillips “special blue”
bilirubin bulb with excess light filtered out using Plexiglas for a duration of 1 hour. The second
half was left in the dark for the duration of 1 hour. The control for this modification was 100 µL
mL of 1 mg/mL FN in phosphate buffered serum at pH 7.4.

Modified Fibronectin Coating of Cell Culture Plates
The modified FN and each respective control were used to coat the wells of either a 24or 6-well plate. The FN solution was allowed to incubate in the dark at 37°C for 24 hours prior
to seeding. After the 24-hour incubation period, the excess FN was removed and the cell culture
plates were allowed to dry (about 20 minutes) in sterile conditions. Absorbance of FN was taken
before and after to ensure protein had adhered to the surface of the cell culture plate.

MTT Proliferation Assay for Fibronectin Coated Cell Culture Plates
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MTT assay was performed as preliminary data to explore cell proliferation prior to
moving forward with cell death assays. Cells were seeded on the modified FN coated 24-well
plates in an amount of 2.5 x 104 cells/ml. Cells were seeded in triplicates. The cells were
allowed to attach for 30 minutes at 37°C. The unattached cells were aspirated, and each well
was washed and refilled with 500 µL DMEM. The cells were incubated at 37°C for 1 hour.
MTT reagent was added in an amount of 50 µL and the cells were incubated for 4 hours at 37°C.
The solution was aspirated and 200 µL of DMSO was added to each well. After 1 minute, 25 µL
of glycine buffer at pH 10.0 was added to adjust pH. Each plate was read within 5 minutes at
560 nm using a plate reader (BioTek Synergy 2).

Flow Cytometry Cell Viability Assay for Fibronectin Coated Cell Culture Plates
Cells were seeded onto 6-well plates coated with modified-FN in an amount of 5.0 x 105
cells/ml. Cells were allowed to attach for 1 hour at 37°C. The cells were UV irradiated for 30
seconds. Cells were allowed to grow at 37°C for 24 hours. DMSO was added to each of the
three instrument controls 8-10 hours prior to analysis. For flow cytometry analysis, the old
media was added to individual tubes and the adhering cells were trypsonized to be collected in
the tubes containing original media and were washed with PBS (pH 7.4). The assay was than
performed according to the Alexa Flour 488 kit and analyzed via BD Sciences Flow Cytometer
and FlowJo Software (Alge et al., 2002; Hingorani, Deng, Elia, Mcintyre, & Mittar, 2011;
Jackson et al., 2015; L. A. Kim et al., 2014). Figure 2.16 depicts how cells are stained using this
method and an example of the defined quadrants of the Annexin-V/PI staining FlowJo analysis.
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Figure 2.16: Depiction of stained cells using Annexin-V FITC/ Propidium Iodide kit. (A)
Mechanism of staining (“BD FACSCalibur,” 2009). (B) Example of quadrant assignment in
FlowJo analysis.

To perform the assay, each tube containing cells was centrifuged at 1000 rpm for 5 minutes.
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The supernatant was aspirated and the pellet was washed with PBS (pH 7.4). The tubes were
centrifuged a second time and the supernatant aspirated. The pellet was suspended in 100 µL of
1X Annexin binding buffer and 5 µL of Annexin-V was added to each sample tube and 1
instrument control tube. The tubes were gently mixed and allowed to incubate at room
temperature in the dark for 20 minutes. The samples were centrifuged at 1000 rpm for 5
minutes. The supernatants were washed with 500 µL of 1X Annexin Binding Buffer and
centrifuged again. The supernatant was aspirated and the pellet suspended in 500 µL of 1X
Annexin Binding Buffer. Right before analysis 1 µL of 500 µg/mL of propidium iodide (PI) was
added to each of the samples and a second instrument control. The third instrument control had
no dye added to it. The samples and instrument controls were gently mixed and put on ice and
kept in the dark while running the instrument. Prior to each sample being subjected to flow
cytometry, the tube was vortexed. FlowJo Software (FlowJo LLC) was used to analyze data.

RPE- Derived Extra Cellular Matrix Growth and Preparation
ARPE-19 cells were seeded onto 24-well cell culture plates and allowed to grow for 4-6
weeks at 37°C and 5% CO2 in order to develop RPE-derived ECMs. Cells were examined and
media changed every 3 days to ensure proper nutrition and healthy growth. Once a monolayer
had formed, adherent cells were gently removed using TrypLE followed by incubation at 37°C
for 7-10 minutes. The plate was gently washed with PBS (pH 7.4) four times to remove cells
and cell debris from the newly formed ECM. The ECM was allowed to dry for 15-20 minutes in
sterile conditions before adding the modifying agents.

Nitration Reaction ECM Modification
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A sterile solution of 200 mM sodium nitrite in pH 5.0 acetate buffer was added in an
amount of 500 µL to each ECM well. A PBS solution at pH 7.4 was added in an amount of 500
µL to each control ECM well. The plates were incubated 7 days at 37°C and 5% CO2. After the
7-day incubation period, the ECM was washed four times with PBS (pH 7.4). An amount of 500
µL of PBS (pH 7.4) was added to each well and incubated 4-24 hours to remove any excess
reagent.

Glycation Reaction ECM Modification
A sterile solution of 50 mM glycolaldehyde in PBS at pH 7.4 was added to each ECM
well in an amount of 500 µL. To each control ECM well, an amount of 500 µL of PBS at pH 7.4
was added. The plates were incubated for 12 hours at 37°C and 5% CO2. After incubation, the
ECM was washed four times with PBS (pH 7.4). An amount of 500 µL of PBS (pH 7.4) was
added to each well and incubated 4-24 hours to remove any excess reagent.

A2E Dark Reaction ECM Modification
Synthetic A2E with a concentration of 18 µM was syringe filtered and added to RPE
derived ECM in an amount of 250 µL. This concentration was chosen because it has been
shown to cause RPE cell stress and a comparable concentration has been found in vivo (Grimm
et al., 2001; Suter et al., 2000). An equal amount of PBS at pH 7.4 was added to each well
containing A2E to ensure a total volume of 500 µL. PBS at pH 7.4 was added to all control

wells in a volume of 500 µL. The plates were incubated 8 hours in the dark at 37°C. The
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reaction was stopped after 8 hours by washing with PBS (pH 7.4) four times. Each well was
then filled to 500 µL with PBS (pH 7.4) and the plate was returned to the incubator for 4-24
hours prior to seeding.

A2E Blue Light Reaction ECM Modification
Synthetic A2E with a concentration of 18 µM was syringe filtered and added to RPE
derived ECM in an amount of 250 µL. An equal amount of PBS at pH 7.4 was added to each
well containing A2E to ensure a total volume of 500 µL. PBS at pH 7.4 was added to all control
wells in a volume of 500 µL. The plates were then blue light irradiated using a Phillips “special
blue” bilirubin bulb with UV light filtered out using Plexiglas for a duration of 1 hour. After 1
hour in the blue light chamber, the plate was incubated for an additional 7 hours at 37°C in the
dark to prevent visible light exposure and continue the modification reaction to the ECM. The
reaction was stopped after 8 hours by washing with PBS (pH 7.4) four times. In order to
compare blue light irradiated A2E reactions with A2E dark reactions directly, the plate was
covered in aluminum foil and set in the dark for 1 hour with the same ambient environment as
the blue light irradiated A2E reaction. Foil was removed after the 1 hour and the plate was
incubated at 37°C in the dark for an additional 7 hours. This served as the control for blue light
irradiated A2E. The reaction was stopped after 8 hours by washing with PBS at pH 7.4 four
times. Each well was then filled to 500 µL with PBS (pH 7.4) and the plate was returned to the
incubator for 4-24 hours prior to seeding.
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MTT Proliferation Assay for Modified ECM
Modified ECM and subsequent control plates were prepared by washing with PBS at pH
7.4 three times and allowed to dry in sterile conditions for 15-20 minutes. Confluent ARPE-19
cells cultured in a T-25 well flask were counted using a hemacytometer. Each well was seeded
with a high density of 5.0 x 104 cells. The DMEM volume was filled to 500 µL in each well
after seeding and the plate was incubated at 37°C and 5% CO2. Cells were incubated to
confluency (confluency time was dependent on the modification conditions and ranged from 4048 hours) prior to assay (Z. Wang, Paik, Del Priore, Burch III Scholar, & Gaillard, 2005). MTT
assay was used to determine cell proliferation for each ECM modification. The procedure
followed the same outline as described above for the proliferation MTT assay for fibronectin
coated cell culture plates. Absorbance was read at 560 nm using a BioTek Synergy 2 plate
reader.

Flow Cytometry Cell Viability Assay for Modified ECM
Flow Cytometry was used to look at cell viability using an Annexin V/PI kit. ECM plates
were prepared and cells were counted using the same method described above. Cells were
seeded on RPE derived ECM in an amount of 2.5 x 105 cells distributed evenly among three
wells for both non-modified and modified ECM 24 well plates (approximately 8.3 x 104
cells/well). Each well was filled to 500 µL total volume using DMEM. After 1 hour of
incubation at 37°C and 5% CO2, the plates were UV-C irradiated for 30 seconds and returned to
the incubator. Cells were allowed to grow at 37°C for a total of 24 hours prior to fluorescence-

activated cell sorting (FACS) analysis using FACSCalibur flow cytometer (BD Biosciences, 78
San Jose, CA, USA). All cells were collected for analysis including any non-adherent cells
obtained from the media. The assay was performed according to the manufacturers
recommendations and FlowJo Software (FlowJo LLC) was used to analyze data (Alge et al.,
2002; Hingorani et al., 2011; Jackson et al., 2015; L. A. Kim et al., 2014). The assay was
performed in the same way it is outlined in the methods for the fibronectin coated cell culture
plates.

Flow Cytometry Cell Death Inhibition Assay for Modified ECM
Three cell death inhibitors were used in this project. The first was a caspase-1 inhibitor.
The caspase-1 inhibitor was Z-VAD-FMK. Z-VAD-FMK is a cell permeable molecule and is
known to inhibit the pro-inflammatory cell death mechanism pyroptosis. Figure 2.17 displays the
molecular structure of Z-VAD-FMK and a schematic of the method in which the molecule is
believed to inhibit pyroptosis. The second cell death inhibitor used was necrostatin-1.
Necrostatin-1 is believed to inhibit necroptosis and necrosis. Figure 2.18 displays the molecular
structure and a schematic of where in the mechanism the molecule inhibits. Necrostatin-1 is an
allosteric inhibitor of RIP1 kinase which is believed to be essential in the tumor necrosis factor-α
induced necrosis and necroptosis. The third cell death inhibitor used was a caspase-3 inhibitor.
Caspase-3 is believed to be the final caspase activated for apoptosis. The caspase-3 inhibitor
used in these studies was Z-DEVD-FMK. Z-DEVD-FMK is a cell-permeable molecule that is
commonly used to inhibit apoptosis. Figure 2.19 displays the molecular structure of Z-DEVDFMK and a schematic of where the molecular inhibits in the cell death pathway. Details on

pyroptosis, necrosis, necroptosis, apoptosis and cell death inhibition is described in Chapters 1 79
and 3.
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Figure 2.17: A) Molecular structure of Z-VAD-FMK; the caspase-1 inhibitor used in these
studies. (B) General schematic of pyroptosis and where the inhibitor impacts the mechanism.
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Figure 2.18: A) Molecular structure of necrostatin-1: the necrosis and necroptosis inhibitor used
in these studies. (B) General schematic of necroptosis and where the inhibitor impacts the
mechanism.
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Figure 2.19. A) Molecular structure of Z-DEVD-FMK; the caspase-3 inhibitor used in these
studies. (B) General schematic of apoptosis and where the inhibitor impacts the mechanism
(Kwak, 2013).
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Cell Death Inhibition using Caspase-1
All RPE-derived ECMs were prepared and modified according to the previously
described ECM methods. The controls for all cell death inhibition experiments were modified
ECM with no inhibitor added. Cells were counted and seeded according to the same methods
described in the cell viability assay. The caspase-1 inhibitor (cas-1) was dissolved in DMSO and
diluted using PBS (pH 7.4). A final concentration of 40 µM was added to 500 µL of cells and
incubated with cells for 15 minutes prior to seeding onto the modified ECM plates. Seeding was
immediately followed by the cell viability FACS analysis as described in the cell viability
methods.

Cell Death Inhibition using Necrostatin-1
All RPE-derived ECMs were prepared and modified according to the previously
described ECM methods. The controls for all cell death inhibition experiments were modified
ECM with no inhibitor added. Cells were counted and seeded according to the same methods
described in the cell viability assay. Necrostatin-1 was dissolved in DMSO and diluted with PBS
(pH 7.4). The Necrostatin-1 solution was added to each modified well to a final concentration of
30 µM immediately after seeding (Degterev et al., 2005; L. A. Kim et al., 2014; Teng et al.,
2005; Vandenabeele et al., 2008). Seeding was immediately followed by the cell viability FACS
analysis as described in the cell viability methods.
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Cell Death Inhibition using Caspase-3
All RPE-derived ECMs were prepared and modified according to the previously
described ECM methods. The controls for all cell death inhibition experiments were modified
ECM with no inhibitor added. Cells were counted and seeded according to the same methods
described in the cell viability assay. The caspase-3 inhibitor (cas-3) was dissolved in DMSO and
diluted using PBS (pH 7.4). A final concentration of 20 µM was added to 500 µL of cells and
incubated with the cells for 1 hour prior to seeding the modified ECM plates (J. R. Sparrow &
Cai, 2001). Seeding was immediately followed by the cell viability FACS analysis as described
in the cell viability methods.

Preparation of Human RPE cells from Donor Tissue
Donor human eyes were purchased from Illinois Eversight (Chicago, IL) and processed
immediately upon receipt. Donor eyes procured from patients previously diagnosed with dry
AMD, wet AMD, Diabetic Retinopathy, multiple eye disorders or no ocular disorder (both age
matched and young donors) were used in this study. The RPE cells were processed as previously
described by Feeney-Burns (Feeney-Burns, 1980). Each donor eye set were treated separately
and no pooling of samples was done. Eyes were carefully dissected with the removal and
collection of the cornea and lens first, placing the tissue in separate 15-mL conical tubes. The
vitreous humor was removed and discarded. The sclera was then cut into a flower shape as
shown in figure 2.20a. A 4 ºC phosphate buffered sucrose solution (100 mM phosphate, 0.32 M
sucrose) was pipetted onto the eye and the neural retina was removed carefully by allowing it to

float apart from the remainder of the retina and cut at the optic nerve. The neural retina and
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buffer was collected and placed into a 15-mL conical tube. The phosphate buffer sucrose
solution was added and the RPE was brushed with a camel hair paintbrush and the buffer was
collected into a 15-mL conical tube. This was repeated numerous times until the brushed buffer
solution was no longer pigmented. The Bruch’s membrane was removed from the remainder of
the eye and collected into a 15-mL conical tube. All tissue was stored at -70 ºC until ready to be
further studied. Table 2.1 summarizes the tissues used in this work.

Preparation of Organic Soluble Lipofuscin from Human Donor RPE Cells
Lipofuscin granules were extracted and isolated from RPE cells previously obtained
continuing the methods as described by Feeney-Burns (Feeney-Burns, 1980). The RPE cells
previously obtained were homogenized then centrifuged at 100 x G for 5 minutes using a
Beckman J2-HS centrifuge and a JA-20 rotor. Figure 2.20 displays a dissected human eye and a
sucrose gradient. A sucrose gradient was made using sucrose solutions layered from highest
density to lowest density using three sucrose solutions at 0.63 M, 1.37 M and 2.25 M (figure
2.20b). The cell supernatant was carefully layered on the top of the sucrose gradient in a thin
layer. The gradient was then centrifuged at 8,500 X G for 20 minutes. The interface between
the top two layers was collected and lyophilized. The organic soluble portion was obtained from
the isolated lipofuscin by Folch extraction using a 1:1:1 ratio of CHCl3: CH3OH: H2O. This
process is depicted in figure 2.21. The organic soluble portion was dried under argon gas and
reconstituted using 250 µl HPLC grade methanol and analyzed using ESI-MS/MS with a PDA
detector. Each sample was carefully handled and protected from light during the entire process.

Samples were analyzed within 0-3 days after preparation to ensure no post-mortem oxidation 85
occurred.

Table 2.1: Donor information for donor globes used in this study.

Donor’s Age
(years)

Donor’s Race

39

Caucasian

44

Caucasian

65

Not given

73

Not Given

87

Caucasian

65

Caucasian

PDR (OU)

73

Caucasian

DR, early Dry AMD

91

Caucasian

Wet AMD, intravitreal
injection treatment

82
81

Not given
Not given

Macular degeneration
Macular degeneration

75

Not given

Wet AMD

80

Not given

DR

80

Not given

PDR

Ocular History
No ocular disease
noted
Lasix surgery
Cataract, no retinal
disease noted
Cataract, no retinal
disease noted
Dry AMD, AREDs
vitamin treatments

Relevant Medical
History
N/A
N/A
Diabetic
N/A
Chronic heart
failure,
Type 2 Diabetic,
esophageal cancer
Type 2 Diabetic
Congestive heart
failure, former
smoker
N/A
N/A
Cardiovascular
disease
Type 2 Diabetic
Type 2 Diabetic,
Chronic heart
failure
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(RPE)
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Figure 2.20: A) Dissected human eye showing retina where RPE cells were obtained. (B)
Sucrose density gradient prior to sample layering.
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1.

2.
Figure 2.21: Steps of obtaining organic soluble lipofuscin. Step 1: Separation of lipofuscin from
other RPE components (Feeney-Burns, 1980). Step 2: Folch extraction procedure.

LC/MS Analysis
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Samples were analyzed on a Thermo-Finnigan LCQ Advantage, while some were
analyzed on a Q-Exactive. The mass spectrometer was set to positive ion mode with a source
voltage of 4.0 kV, capillary voltage of 42 V and a capillary temperature of 200°C. The mass-tocharge ratios were collected from 200 to 2000 m/z and normalized collision energy of 25-55%
(depending on sample) was used for MSMS data. The lipofuscin samples were separated using
Surveyor LC system with a Phenomenex Kinetex reverse phase 2.6u C18 column. The gradient
of 80% methanol 20% water for 30 minutes and 80-100% methanol for 90 minutes was used
with a flow rate of 0.2 ml/min. All solvents used in the mobile phase also contained 0.1% formic
acid.

Nitro-A2E Synthesis
Previously synthesized A2E was diluted to 43 µM in methanol. An amount of 5.0 mL of
the 43 µM solution was dried and suspended in 500 µL of methanol and placed in a 10-mL round
bottom flask. An amount of 1.0 mL of ammonium acetate buffer (0.25 M, pH 5.4) and 500 µL
of 200 mM sodium nitrite was added to a small vial and inverted to mix. The solution was added
dropwise to the A2E-containing round bottom flask. The flask was covered in aluminum foil
and allowed to stir in the dark for 4 days. Millipore C-18 Zip Tips® were used to desalt the
nitrated A2E. The Zip Tips® were prewashed with methanol, equilibrated with water (0.1%
formic acid) and washed with 0.1% formic acid water. Samples were then eluted using
methanol. The desalted sample was diluted to 30 µL using methanol.

A2E Amino Acid Reactions

89

Synthesized A2E in a concentration of 18 µM in methanol was added to one of eight
amino acids. Amino acids tested included the following: L-Valine, L-Leucine, L-Phenylalanine,
L-Tryptophan, L-Cysteine, L-Tyrosine, L-Arginine and L-Lysine. A 500 µL solution of 1.0
mg/mL of the amino acid was prepared using synthesized 18 µM A2E in methanol. The solution
was divided into two 250 µL aliquots. One aliquot was placed in the blue light chamber while
the other was placed in complete darkness each for a time of 1 hour. The vials were then stored
at -20 ºC to be analyzed using LC-MS/MS and compared to spectrums obtained from lipofuscin
samples.

CHAPTER 3
EXPLORATION OF RPE CELL DEATH MECHANISMS IN RELATION TO AGERELATED MACULAR DEGENERATION

Introduction
Age-related macular degeneration (AMD) is the leading cause of blindness in developed
countries. A well-known pathogenic characteristic of AMD is retinal pigment epithelial (RPE)
cell death, however, the mechanism of cell death is not well understood. Several possible
contributing factors have been postulated, including aging, oxidative stress, lipofuscin
accumulation and blue light exposure (Dorey et al., 1989; Murdaugh et al., 2009a; Sparrow &
Cai, 2001; Sparrow et al., 2000; Suter et al., 2000).
Bruch’s Membrane (BM) serves as the basement membrane and extracellular matrix
(ECM) for RPE cells. The ECM serves as a blood-ocular barrier, a structural support and
microenvironment for RPE cells (Binder & Falkner-Radler, 2008; Fernandez-Godino, Garland,
& Pierce, 2015). RPE cells adhere to the innermost layer of Bruch’s membrane where integrinprotein interactions are required for cell attachment. Figure 3.1 illustrates the relationship
between BM and RPE.
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Figure 3.1: Cartoon depiction of the relationship between retinal layers (The Angiogeneis
Foundation, 2016).

It has been illustrated that RPE cells are able to differentiate on healthy to moderately 92
damaged BM, but when the BM is severely damaged, either physically or by posttranslational
modifications, RPE cells are unable to grow (Gillery & Jaisson, 2014; Shiragami, Matsuo,
Shiraga, & Matsuo, 1998). Several different posttranslational modifications (e.g. glycation,
nitration, etc.) of ECM proteins have been hypothesized to be responsible for RPE cell death.
Several groups have shown these modifications to the ECM proteins negatively impact RPE cell
attachment, proliferation and differentiation (Cavallotti, 2008; Fernandez-Godino et al., 2015;
Murdaugh, Wang, Del Priore, Dillon, & Gaillard, 2010b; Nita, Strzałka-Mrozik, Grzybowski,
Mazurek, & Romaniuk, 2014; Sun et al., 2007; Z. Wang et al., 2005). Ultimately, such
posttranslational modifications may be the cause of cell death. One of these posttranslational
modifications is non-enzymatic glycation, which is defined as the reaction involving the binding
of reducing sugars and their by-products to the free amino groups of proteins (Gillery & Jaisson,
2014). The mechanism for which glycation of proteins occurs is through Maillard reactions
(Gillery & Jaisson, 2014; Glenn et al., 2009; Nagai et al., 2000). Products of Maillard reactions
have been implicated in product accumulation and protein cross-linking (Sell & Monnir, 1989).
Another type of posttranslational modification is non-enzymatic nitration. This specific
modification involves nitrite ion, which is abundant under chronic inflammation and cigarette
smoking. Nitrite can be formed as a by-product of nitric oxide and nitrogen dioxide gases, and
has been studied as a non-enzymatic age-related modification to ECM proteins and collagen
cross-linking (Paik et al., 2001; Paik, Ramey, Dillon, & Tilson, 1997; Z. Wang et al., 2005).
More interestingly, under chronic inflammation or cigarette smoking, high levels of nitric oxide
and nitrogen dioxide gases have been physiologically detected (Farrell, Blake, Palmer, &
Moncada, 1992; Fields et al., 2015; Kaur & Halliwell, 1994; Paik et al., 2001; Z. Wang et al.,

2005). Non-enzymatic nitration of ECM proteins and collagen cross-linking occurring with
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chronic inflammation has been associated with AMD (Crabb et al., 2002; Mullins et al., 2000; Z.
Wang et al., 2005). Additionally, modifications to synthetic ECM (Matrigel) via the nitrite ion
have been associated with increased RPE cell death. Specifically, Wang et. al. reported a
significant increase in apoptotic and necrotic RPE cell populations when cells were allowed to
grow on a nitrite-modified Matrigel (Z. Wang et al., 2005). The accumulation of these
modifications in the retina, specifically to ECM proteins required for cell attachment, are
strongly correlated with the progression of AMD (Bhatwadekar et al., 2008; Gillery & Jaisson,
2014; Z. Wang et al., 2005).
Another type of posttranslational modification is related to blue light irradiation of A2E.
This chemical compound is a widely studied fluorophore that has been identified in retinal
lipofuscin, a natural build-up of cellular waste especially with age and retinal disease. A2E is
thought to be synthesized biologically as a chemical waste of the visual cycle (Gaillard et al.,
2004; Sparrow, Parish, Hashimoto, & Nakanishi, 1999; Sparrow et al., 2003). A2E has been
observed to readily undergo oxidation, where the oxidation products are believed to accumulate
with age (Avalle et al., 2004; J. Dillon et al., 2004). A2E has also been observed to mediate blue
light damage and increase in concentration with light exposure and age (Dillon et al., 2004;
Murdaugh et al., 2010b). Blue light irradiation of A2E and A2E oxidation products are thought
to form highly reactive species that have deleterious effects on ECM proteins (Avalle et al.,
2004; Dillon et al., 2004; Thao et al., 2014; Wang et al., 2006). The retinal accumulations of
A2E and its products derived from blue light exposure have been previously connected with
AMD and apoptotic RPE cell death (Grimm et al., 2001; Sparrow & Cai, 2001; Wang et al.,
2005).

Fibronectin (FN) is a major ECM glycoprotein present within Bruch’s Membrane. It 94
is known to play an important role in RPE cell attachment (An et al., 2006; Tezel, Del Priore, &
Kaplan, 2004). Specifically, the amino acid sequence RGD binds the α5β1-integrin region,
where the RPE adheres to BM (Figure 3.2). Previous work performed, primarily by the Gaillard
group, has provided strong evidence that suggests modified FN may effect the pathogenesis of
AMD (An et al., 2006; Murdaugh, Dillon, & Gaillard, 2009; Thao, Renfus, Dillon, & Gaillard,
2014; Wang et al., 2005). Particularly, it has previously been reported that the modifications to
FN occur preferentially on tyrosine, lysine and arginine residues when the protein is subjected to
non-enzymatic nitration, non-enzymatic glycation and A2E oxidation conditions (Murdaugh et
al., 2009; Thao et al., 2014). Modifications to the arginine residue in the RGD binding sequence
could potentially impact proper cell attachment and lead to RPE cell death.
Apoptosis, autophagy, and necrosis are the most common cell death pathways. Apoptosis
is programmed cell death mediated by a cascade of caspase activation and is irreversible. It is
characterized by chromatin condensation, membrane protrusion and cellular shrinkage (Paoli et
al., 2013; Teng et al., 2005; Vandenabeele et al., 2008). Autophagy is a cell self-digestion
process critical to organismal survival where cells are able to maintain intracellular homeostasis.
Cell death associated with autophagy is referred to as autophagic cell death (ACD), which is
induced when an apoptotic signaling is perturbed and is defined by morphological changes to the
cell. Specifically, the morphological changes include autophagic vacuoles within the cytoplasm
of a dying cell (Kroemer & Levine, 2008; Vandenabeele et al., 2008). ACD differs from
apoptosis due to the absence of chromatin condensation and the accumulation of LC3-II (Duprez,
Wirawan, Berghe, & Vandenabeele, 2009; Kroemer & Levine, 2008).
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Figure 3.2: Secondary structure of human fibronectin type III tenth domain. Image is depicted as
a cartoon and psuedocolored by amino acid. Highlighted, is the RGD amino acid sequence in
fibronectin required for RPE attachment. PDB file: 1FNA

Necrosis is another type of cell death. It is characterized by mitochondrial impairment,

and cell swelling followed by cell lyses. When the cell membrane ruptures, subsequent release 96
of the cell contents induces an inflammatory response (Linkermann & Green, 2014; Teng et al.,
2005; Vandenabeele et al., 2008). More recently, other types of cell death mechanisms have been
reported. As an example, necroptosis is a programmed form of necrosis and is dependent upon
receptor interacting protein kinase 1 and 3 (RIPK1/3) (Kaczmarek et al., 2013; Linkermann &
Green, 2014; W. Zhou & Yuan, 2014). Pyroptosis is a newly emerging cell death mechanism
that has been recently identified as a separate cell death pathway. This mechanism is unique as a
pro-inflammatory type of programed cell death that specifically depends on the caspase-1
activation (Doitsh et al., 2014; Duprez et al., 2009; Hanus et al., 2013). Figure 3.3-3.6 displays
the biochemical pathways for these cell death mechanisms.
The complete cell death mechanism in AMD development is not well understood.
Several studies have shown that RPE cells undergo apoptosis due to oxidative and mechanical
stress. In contrast, other studies demonstrate that RPE cells die via necrosis as a result of
oxidation and inflammation. These conditions have been correlated as underlying causes of
AMD by several groups (Grimm et al., 2001; Hanus et al., 2013; J. R. Sparrow & Cai, 2001;
Stress et al., 2014; Suter et al., 2000). A recent report from Kim et. al. focused on RPE cell death
initiated by drug toxicity and found that the observed pathways were more complicated than
previously reported. The results indicated contributions of cell death pathways from pyroptosis
and necroptosis (L. A. Kim et al., 2014). Again, AMD is a multi-factorial disease, thus the exact
cell death mechanism of RPE cells is complicated.
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Figure 3.3: Biochemical pathway of apoptotic cell death (Duprez et al., 2009).
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Figure 3.4: Biochemical pathway of necrotic cell death (Duprez et al., 2009).
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Figure 3.5: Biochemical pathway of autophagic cell death (Duprez et al., 2009).
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Figure 3.6: Biochemical pathway of pyroptotic cell death (Duprez et al., 2009).

Therefore, this study aims to further the understanding of the cell death mechanism
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of cell death during aging, blue light mediated oxidative stress and inflammation as has been
associated with AMD. Given the biochemistry of the retina, especially the relationship between
BM and RPE cells (as described in detail in Chapter 1) it is of great interest to investigate the cell
death mechanisms of RPE cells under these various stresses. While other studies have indicated
apoptosis and necrosis as primary cell death mechanisms associated with AMD, this work aims
to investigate additional cell death mechanisms using more sensitive methods. We hypothesize
that there is an overlap of cell death pathways initiating in response to specific ECM
modifications such as glycation, nitration, damage mediated by A2E and blue light irradiated
A2E. Using inflammation, aging and oxidative stress models for potential pathogeneses of
AMD, we investigated potential cell death pathways in ARPE-19 cells. These investigations can
lead to a better understanding of both why and how RPE cells are characteristically dying in
patients diagnosed with AMD. Because our knowledge on the pathogenesis and progression of
the disease is limited, these studies can aid in further understanding the changes to the
biochemistry of the retina that is inflicted with AMD.

Results
Fibronectin-Coated Cell Culture Plates
To begin studying the implications of inflammation, glycation and oxidative stress related
to AMD, we first considered the cell death mechanism of ARPE-19 cells. The initial
investigation of the effects of modified ECM, especially FN, on ARPE-19 cell death was
performed by modifying human FN and then coating 24-well plates. Various modifications to

FN such as non-enzymatic nitration, glycation via glycolaldehyde and blue light mediated
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A2E were used as models for inflammation, aging, and oxidative stress, respectively. A
comparison was made between the modified FN and its control to ensure that modifications
occurred before proceeding.
Non-enzymatic nitration via nitrite of FN was one of the modifications performed.
Chronic inflammation and iNOS activity has been shown to occur in low pH microenvironments
biologically. Therefore, the nitration reaction was done at a pH 5.0 to model inflammatory
conditions. Additionally, an acidic pH of the nitration solution is typical to increase the reaction
rate. Because of the acidic pH, nitrated tyrosine residues have a maximum absorbance
wavelength of 350 nm. The absorbance spectrum indicated the nitrated FN had an increase
absorbance at a wavelength of 350 nm (Figure 3.7 B). As shown in figure 3.7 B, the UV data
indicated there was no observable nitration for the control FN.
FN was also modified with glycolaldehyde. Glycolaldehyde was the glycating agent
chosen due to the high reactivity the molecule possesses. Glycation can be achieved in a shorter
time using glycolaldehyde compared to other common glycating agents such as glucose. AGEs
produced from proteins modified with glycolaldehyde are typically excited at 325 nm and
emission monitored at λm of 420 nm. Results indicated an increase in fluorescence intensity
occurred at the maximum wavelength of 420 nm for the glycated FN (figure 3.7A). As depicted
in figure 3.7 A, the data showed there was no observable fluorescent emission at a wavelength of
420 nm for the control.
The modifications of A2E on FN were monitored with UV/Vis. A2E is highly conjugated
and orange-yellow in color. When exposed to BL, the conjugation is interrupted causing a
change in the absorbance spectrum as reactive aldehydes and ketones form (figure 3.7 D).
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Figure 3.7: Modified FN detection and verification. (A) Glycated FN at excitation wavelength
325 nm. (B) Absorbance of nitrated and control FN verifying nitration of tyrosine residues had
occurred. (C) Absorbance of A2E and BL irradiated A2E (A2E + BL) modified FN in
comparison to the control. (D) Image of blue light irradiated A2E modified FN on the left and
the right is A2E modified FN.
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It is hypothesized that the photooxidation products formed as a result of blue-light irradiation
will react with susceptible protein residues as described in the literature (M. T. Thao et al.,
2014). A2E has distinct absorbance wavelength maximums of 330 nm and 430 nm (Figure 3.8).
Upon modifying FN, the endproducts/modified FN has a unique absorbance for both dark and
blue light conditions (Figure 3.7 C), where the A2E dark modified FN was comparable to the
absorbance of A2E. As shown in figure 3.7 C, the absorbance data indicated there was no
observable absorbance for the control FN.
Finally, the absorbance of modified and control FN was measured once it coated the cell
culture plates. Beer’s Law describes a direct proportionality between absorbance and
concentration of a solution. Because of this proportional relationship, a decrease in absorption
would indicate a decrease in solution concentration. Absorbance (λ=280 nm) of modified FN
was measured before coating the wells. After coating the cell culture plates, the excess FN
solution was recovered and absorbance (λ=280 nm) was measured again. The difference in
absorption was calculated in order to verify that FN coated the 24-well plates. Table 3.1 displays
the absorbance change of FN for each modification. Because results indicated the FN absorbance
measurements decreased and by employing Beer’s Law, it can be implied that the FN
concentration is also decreasing. These results verify that FN was being deposited onto the cell
culture 24-well plates. The cells were then seeded onto the FN coated wells and cell viability
assays were performed as described in Chapter 2. Once these results were collected, we were
able to continue our cell viability studies.
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Figure 3.8: UV/Vis absorption and mass spectrum of synthesized A2E (18 µM).
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Table 3.1: Absorbance values of modified FN, monitored at a wavelength of 280 nm before and
after cell culture well deposition. Each modification produced a negative difference indicating
some of the protein was deposited onto the culture plates. The data is presented as means ±
standard deviation where n=7.

ODt

FN Nitration

FN Glycation

FN A2E

FN A2E + BL

Before

1.14 ± 0.03

1.01 ± 0.02

1.73 ± 0.03

1.56 ± 0.02

0.052 ± 0.006

0.321 ± 0.010

0.248 ± 0.007

0.554 ± 0.009

-1.09 ± 0.03

-0.686 ±

-1.48 ± 0.03

-1.01 ± 0.02

Coating
After
Coating
Difference
(ODf-ODi)

0.018
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The Effects of ARPE-19 Cell Proliferation on Modified Fibronectin Coated Cell Culture Plates

MTT assay was used to assess ARPE-19 cell proliferation. The absorbance was
monitored at a wavelength of 560 nm because MTT is reduced to insoluble formazan by the
mitochondria of viable cells. Figure 3.9 shows the MTT assay results for ARPE-19 cells on each
of the FN modifications and its respective control. Each modification showed a significant
decrease in absorbance, except for the nitrated FN. The decrease in absorbance can be
associated with decreased proliferation of viable cells. The greatest decrease in absorbance
observed was the glycated FN followed by blue light irradiated A2E FN. These results suggest
glycated FN and blue light irradiated A2E FN had the greatest impact on mitochondrial activity
of ARPE-19 cells. More specifically, these results indicated significant (as compared to the
respective control) reduced activity of mitochondrial oxidoreductase enzymes in ARPE-19 cells
that were seeded on glycated FN, A2E modified FN and A2E +BL modified FN.
The physical characteristics of ARPE-19 cells were used as a qualitative method of cell
proliferation. ARPE-19 cells are naturally adherent cells known to adhere to the surface of a
tissue culture plate in as few as 30 minutes. Therefore, the cells were monitored 1 hour after
seeding to investigate whether cells were adhering, beginning to adhere, or not adhering to the
surface of the specific modified FN-coated well. A scale from 1-3 was used to describe the
degree of adherence of the cells where 3 was adhering, 2 was beginning to adhere and 1 was not
adhering (figure 3.10).

108

1.000

Control
FN
Modified
FN

OD (560 nm)

0.800

0.600
*
0.400
**
**

0.200

0.000
Nitrated

Glycated

A2E

A2E + BL

Figure 3.9: MTT assay results of cells seeded onto modified FN coated cell culture plates. All
except nitrated FN indicate a decrease in cell proliferation as determined by mitochondrial
activity of the cells. All data are represented as means with ± standard deviation with n = 10 for
nitrated, n=4 for glycated, n=6 for all A2E modifications. Statistical analysis was done using a
two tailed Student’s T Test where *p< 0.05, **p<0.01.
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Figure 3.10: Cell images taken at two time points after seeding (40x magnification): 1 hour and
24 hours. Images are displayed for all FN modifications including a non-modified FN control.
After 24 hours of growth a change in morphology is evident in the A2E modifications and
proliferation appears to be decreased especially under glycated FN.

All cells were observed using a light microscope with 10x objective lens and images were
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taken with a camera. All modifications shown in figure 3.10 were from cell populations seeded
with the same cell density and using the same cell population. Cells were rated as a 3 for the
nitrated FN, meaning there was no observable difference in cell adherence on the surface of the
nitrated FN and control FN coated wells. Cells seeded on glycated FN coated plates were rated
as a 1 due to the delay in adherence and apparent decrease in number of cells. For the A2E FN
modifications (dark and blue light conditions) cells were rated at a 2 for adherence.
Additionally, for the A2E FN modifications a visible change in morphology was depicted where
cells were malformed and elongated. RPE cells are characteristically able to undergo significant
recovery in response to stress. In order to examine if any morphological recovery occurred,
images of cells were taken after 24 hours of growth to compare to the populations 1 hour after
seeding (figure 3.10). After 24 hours of growth, while some recovery of morphology was evident
in the images, the morphology continued to be affected by both of the A2E modifications. All
FN modification conditions appeared to have a decrease in proliferation especially evident in
glycated and A2E + BL FN. These results are in agreement with the MTT assay results (figure
3.9).

The Effects of Cell Viability of APRE-19 Cells on Modified Fibronectin Coated Cell Culture
Plates

Cell death mechanisms were determined by using Annexin-V Alexa 488 (Annexin-V)
and propidium iodide (PI) assays. As a result of the beginning stages of apoptosis,
phosphatidylserine is translocated from the inner leaflet of the cell membrane to the outer leaflet.

Once this occurs, Annexin-V is able to bind to the phosphatidylserine molecules located on 111
the outer leaflet of the cell membrane. PI is a membrane impermeable dye that targets DNA
within the cell. As cells continue to undergo cell death, the cell membrane becomes more
permeable thus allowing PI to pass through the cell membrane (see figure 2.17). Both dyes have
a maximum excitation at a wavelength of 488 nm; however, PI has a maximum emission
wavelength of 617 nm and Annexin-V Alexa 488 emits at 520 nm. Depending on the degree of
cell viability, cells were labeled with these dyes and, using flow cytometry, then sorted based on
the fluorescence emission. The cell populations were gated into four quadrants according to
each control with each quadrant population representing the degree of cell death. Quadrant 1
contains cells that have stained negative for Annexin-V and stained positive for PI (Ann-/PI+)
which is indicative for the non-viable cell population via necrosis. Quadrant 2 contains cells that
have been stained positive for both Annexin-V and PI (Ann+/PI+), which is indicative of nonviable cells via late apoptosis or necrosis. Quadrant 3 contains cells that have stained positive for
Annexin-V and stained negative for PI (Ann+/PI-), which is indicative of cells undergoing early
apoptosis. Quadrant 4 contains cells that have been stained negative for both Annexin-V and PI
(Ann-/PI-), which is indicative of viable cells. A general flow cytometry gated image defining
the parameters of this assay is depicted in figure 2.16.
We used the Annexin V/PI assay to further investigate ARPE-19 cells on modified FN by
nitration, glycation, and BL + A2E. A representative flow cytometry graph is displayed in Figure
3.11 for ARPE-19 cells on nitrated FN and non-modified FN. Both cell types are abundant in
Quadrant 4, being negative for both Annexin V and PI. These results indicated that these ARPE19 cells were viable and there were no significant changes between the control and nitrated
groups, which was in agreement with the results from the MTT assay. Similar trends were

observed with ARPE-19 cells on glycated FN (Figure 3.12). Results from the MTT assay
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inferred that the ARPE-19 cells that were grown on glycated FN entered a slower metabolic state
and converted MTT to formazan at a slower rate than normal functioning cells. Although the
decrease in MTT absorbance is often associated with less viable cells, it is more indicative of
mitochondrial health. Thus, these findings differed from the MTT results. As seen in figure 3.12
and figure 3.13, flow cytometry results indicated no significant difference when compared to the
control. Flow cytometry results indicated no significant changes in cell viability for all FN
modifications. In order to validate these observations, these studies were continued using
ARPE-19 derived ECM in place of FN.

The Effects of Cell Proliferation of ARPE-19 Cells on Modified RPE-Derived Extracellular
Matrix
FN represented only one protein present in the ECM, so the complete ECM was used to
validate the results observed with FN. ARPE-19 cells were grown on RPE-derived ECM where
the same modifications were used to investigate cell proliferation. MTT assay and its results
were calculated as described previously. Figure 3.14 shows MTT absorbance results. These data
indicated that nitration had the most pronounced effect on cell viability. Modifications made by
glycation or via A2E reaction diminished cell proliferation but to a lesser extent. A significant
drop in cell proliferation was not observed when comparing the blue light irradiated A2E
(A2E+BL) reaction and blue light (BL) control. These results indicated a significant reduction in
mitochondrial oxidoreductase enzymes for nitrated, glycated and A2E modifications.
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Figure 3.12: Representative flow cytometry quadrant data for a glycated FN modification
experiment. (A) Control for glycation reaction. (B) Glycated FN cell viability quadrant data. All
parameters were kept constant under all conditions and no significant change occurred in cell
viability. This experiment was repeated for a total of seven experiments with similar results.
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Figure 3.13: Representative flow cytometry quadrant data for an A2E FN modification
experiment. (A) A2E dark FN modification. (B) A2E + BL FN modification cell viability
quadrant data. All parameters were kept constant under all conditions and no significant change
occurred in cell viability. This experiment was repeated for a total of seven experiments with
similar results.
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Figure 3.14: MTT results for all ECM modifications. MTT assay was performed after 40-48
hours of cell incubation. The solid gray represents cell proliferation for the control for each
reaction. The patterned column represents the cell proliferation on the modified ECM. The data
is represented as the mean ± the standard deviation (n=6) of absorption at 560 nm. Student’s 2tailed T-test was performed to determine the p-values. *p<0.01; **p<0.001.

This differed from the FN MTT assay results in that the FN results showed no significant
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change in mitochondrial activity in the nitrated FN and indicated a decrease in mitochondrial
activity in the A2E + BL FN modifications. These variances prompted the necessity for a more
sensitive cell death assay for ECM modifications as found in flow cytometry.
The Effects of Cell Viability of APRE-19 Cells on Modified RPE Derived ECM
For further clarification and sensitivity, flow cytometry was employed to investigate cell
viability of ARPE-19 cells on modified RPE-derived ECM. The same Annexin-V/PI assay that
was used in the FN studies was used to determine the extent of cell viability. For each
experiment performed, the ECMs were derived from the human RPE cell line, ARPE-19.
Confluent cells grown in a 60 mm cell culture plate were used to seed the ECMs for each
experiment. Once the ECM was derived, cells that were adhering to the surface were gently
removed. After the cells were removed, the ECM was subjected to a modification reaction using
either sodium nitrite, glycolaldehyde, A2E or A2E coupled with blue light irradiation (see
Chapter 2). The controls for these experiments were non-modified ECM, the details of which
are described in Chapter 2. Following the reaction for each modification, cells were seeded
using confluent cells from a T-25 cell culture flask. The cells were counted and calculated for
seeding an amount of 2.5 x 105 cells. In order to allow enough surface area for cells to properly
grow, this count was divided evenly among six wells for the control and six wells for the treated
(about 41,667 cells/well) wells of the ECM-containing 24-well plate. A set of three modified
ECMs was seeded with cells from separate T-25 cell culture flasks. Each flask contained cells of
the same passage number to ensure proper biological experimental replication. Figure 3.15
displays a diagram of this experimental set up.
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Plate: ECM-X a

Plate: ECM-X b

Plate: ECM-X c
Figure 3.15: General diagram depicted experimental design for ECM cell studies.

Additionally, a 35 mm cell culture plate was seeded for use as an instrument control for flow 119
cytometry experiments. After the newly seeded cells were allowed to grow for 24 hours, the cells
were prepped for flow cytometry experiments using the Annexin V/PI assay. Details of the
experimental methods for this assay are described in Chapter 2. All cells from the control wells
of one ECM were pooled into one FACS tube and labeled as the experimental control. All cells
from the modified wells from the same ECM were pooled into one FACS tube and labeled as the
experimental treatment. Figure 3.16 displays a diagram outlining the flow cytometry
experimental set up. While care was taken to ensure each measurement of one experiment was a
biological replicate of the others, the ECMs were grown from cells grown in one 60 mm cell
culture plate. Therefore, three measurements were taken as a part of one ECM experiment. All
results presented in this section are representative of these three measurements obtained.
The four quadrants were gated and defined as previously described in the FN cell
viability studies. Figure 3.17 demonstrates the representative FACS data for ARPE-19 cells on a
nitrated ECM. As seen in the figure, more cells were present in quadrant 3 when these cells were
plated onto nitrated ECM compared to the control. This quadrant indicated that ARPE-19 cells
plated onto nitrated ECM had entered into early apoptosis. ARPE-19 cells that were plated onto a
glycated ECM also entered early apoptosis as indicated in the representative data (Figure 3.18).
The glycation flow cytometry quadrant data are representatively displayed in figure 3.18. ARPE19 cells that were plated onto an ECM modified by A2E significantly differed from results of
nitration and glycation. As shown in Figure 3.19, the cell density was highest in quadrant 2
suggesting a late apoptotic/necrotic state. This type of cell death mechanism was also observed
when ARPE-19 cells were plated onto a BL irradiated A2E modified ECM as shown in Figure
3.20.
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Figure 3.16: Diagram of flow cytometry experimental design for ECM cell viability studies.
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Figure 3.17: Representative FACS data for nitration modification showing results of one
experiment. All data was gated based off of each respective control. Three measurements were
performed for this experiment. Each reaction with its respective control was obtained at the
same instrument parameters with 1.0 x 104 cell count for analysis. The X-axis displays the
Annexin-V Alexa488 (AnnexinV) fluorescence intensity and the y-axis displays the propidium
iodide (PI) fluorescence intensity. Image A displays the control (non-modified) data. Image B
displays the nitration data.
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Figure 3.18: Representative FACS data for glycation modification showing results of one
experiment. All data was gated based off of each respective control. Three measurements were
performed for this experiment. Each reaction with its respective control was obtained at the
same instrument parameters with 1.0 x 104 cell count for analysis. The X-axis displays the
Annexin-V Alexa488 (AnnexinV) fluorescence intensity and the y-axis displays the propidium
iodide (PI) fluorescence intensity. Image A displays the control (non-modified) data. Image B
displays the glycation data.
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Figure 3.19: Representative FACS data for the A2E dark modification showing results of one
experiment. All data was gated based off of each respective control. Three measurements were
performed for this experiment. Each reaction with its respective control was obtained at the
same instrument parameters with 1.0 x 104 cell count for analysis. The X-axis displays the
Annexin-V Alexa488 (AnnexinV) fluorescence intensity and the y-axis displays the propidium
iodide (PI) fluorescence intensity. Image A displays the control (non-modified) data. Image B
displays the A2E dark data.
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Figure 3.20: Representative FACS data of A2E + BL showing results of one experiment. All
data was gated based off of each respective control. Three measurements were performed for
this experiment. Each reaction with its respective control was obtained at the same instrument
parameters with 1.0 x 104 cell count for analysis. The X-axis displays the Annexin-V Alexa488
(AnnexinV) fluorescence intensity and the y-axis displays the propidium iodide (PI) fluorescence
intensity. Image A displays data from the BL control. Image B displays the data from A2E +
BL.

Overall, each modified ECM had an effect on cell viability and its associated cell death

125

mechanism was identified. Using the flow cytometry data for each experiment and implementing
FlowJo software, percentages as a representation of the total cell count from FACS analysis (1 x
104 cells) can be obtained and displayed graphically. Applying Student’s T-Test using the
percentages obtained from FlowJo analysis and Microsoft Excel a p-value can be obtained. The
results of these analyses showed quantitative information. It was observed that 55% of the
ARPE-19 cells seeded entered early apoptotic and late apoptotic/necrotic states when they were
plated onto nitrated ECM as depicted in Figure 3.21A. ARPE-19 cells plated onto glycated
ECM resulted in 66% of cells seeded entered into early apoptotic states (figure 3.21B). These
results suggested the main cell death pathway for the glycation modification was apoptosis.
Furthermore, modifications due to A2E reactions are graphically depicted in figure 3.22. In dark
conditions, A2E modifications resulted in an overall 61% cell viability decrease due to late
apoptosis and necrosis (figure 3.22A). Similarly, A2E + BL caused 73% of ARPE-19 cells
seeded to enter late apoptosis and necrosis (Figure 3.22B). Additionally, data indicated that A2E
and A2E + BL were the only modifications where significant increases in necrotic cell
populations were observed. This proposes A2E and A2E +BL modifications to ECM may be
partially inducing necrotic cell death, rather than apoptosis as previously reported (Suter et al.,
2000). The A2E molecule has been shown to increase in concentration in tissue obtained from
donors that have been diagnosed with AMD (De & Sakmar, 2002; Mihai & Washington, 2014).
The current results suggested that oxidative stress due to the A2E molecule might be partially
responsible for the characteristic RPE cell death as noted in AMD patients. Figure 3.23 shows
graphical representations of these data.

126

A

B

Figure 3.21: Graphical representation of FACS results. All quadrants are represented as follows:
Ann-/PI- (viable), Ann+/PI- (early apoptotic), Ann+/PI+ (late apoptotic/necrotic) and Ann-/PI+
(necrotic) cell % of 1.0 x 104 cells analyzed. All control means under both nitration and
glycation were comparable. (A) Nitration modification compared to its respective control. (B)
Glycation modification compared to its respective control. All data are represented as mean ± SD
(n=3) and student’s T-Test was performed with 2-tailed analysis. *p<0.01, **p<0.0001,
***p<0.00001 compared to the modification’s control.
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Figure 3.22: Graphical representation of FACS results. All quadrants are represented as follows:
Ann-/PI- (viable), Ann+/PI- (early apoptotic), Ann+/PI+ (late apoptotic/necrotic) and Ann-/PI+
(necrotic) cell % of 1.0 x 104 cells analyzed. (A) A2E ECM modified cell viability in dark
conditions. The A2E control means were comparable to both nitration and glycation controls
with no statistically significant differences. (B) A2E + BL compared to BL. All data are
represented as mean ± SD (n=3) and student’s T-Test was performed with 2-tailed analysis.
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001
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Figure 3.23: Flow cytometry viable population of controls for each modification. All
modifications had individual controls due to their reaction conditions. All controls were
comparable with the exception of blue light.

When graphically representing the data and performing statistical analysis on all control
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viable populations, results showed all modification controls as being comparable with the
exception of the BL modification control (figure 3.23). The data suggested BL contributed to a
decrease in cell viability, however the changes in viability with the A2E+BL population, were of
a significantly larger magnitude. This was not a surprising result, as several groups (including
previous work performed by the Gaillard group) have reported blue light irradiation to be
deleterious to the retina (James Dillon et al., 2004; Kuse, Ogawa, Tsuruma, Shimazawa, & Hara,
2015; Janet R. Sparrow et al., 2000). Further investigation was done to determine how the effect
of BL irradiation on A2E compared to A2E without BL irradiation. The A2E dark reaction was
modified to model the A2E + BL reaction as discussed in the methods section to be treated as the
control (figure 3.24). Results indicated a significant decrease in overall cell viability where cells
plated entered late apoptotic/necrotic states. These results further support the hypothesis that
A2E + BL may be more deleterious to RPE cells than A2E.
The Exact Cell Death Mechanism of ARPE-19 Cell on Modified RPE-Extracellular Matrix
To further identify the cell death pathway involved in the RPE cell death, inhibitors
specific to each cell death pathway were added. Three cell death pathway inhibitors were used:
caspase-1 inhibitor (Cas-1) for inhibition of pyroptosis, caspase-3 inhibitor (Cas-3) for inhibition
of apoptosis, and necrostatin-1 for inhibition of necroptosis and necrosis (figure 2.17-2.19). The
methods of the ECM growth and modification were performed as described in the previous
section. The control for these experiments was modified ECM with no inhibitor added. Each cell
death mechanism experiment was executed once with a total of three measurements obtained as
illustrated in figure 3.15 and 3.16.
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Figure 3.24: Cell viability data comparing A2E and A2E+BL. (A) Representative FACS data of
control (A2E dark) from one experiment. (B) FACS data of A2E+BL from one experiment. (C)
Graphical depiction of the two modifications under the same instrumental conditions. Data is
represented as mean ± SD (n=3) and Student’s 2-tailed T-test was performed. *p<0.05

A series of histograms as representative raw data obtained from flow cytometry of
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ARPE-19 cells plated on the nitrated ECM modification with each of the inhibitors is illustrated
in figure 3.25. The series of histograms gives a visual representation of the viable cell population
(AnnexinV-) recovery with the addition of each inhibitor. After cell death inhibitors were added
to the modified ECM the viable cell population increased.
Flow cytometry data for cells seeded onto modified ECM was collected and analyzed
using the same gating methods as described above. Figure 3.26-3.27 demonstrates the
representative flow cytometry data for ARPE-19 cells seeded on nitrated and glycated ECM,
respectively, with inhibitors. The results indicated a denser cell population in the quadrant 4 of
the flow cytometry data. These data suggested recovery of ARPE-19 cell death with each added
inhibitor.
Cell viability of ARPE-19 cells plated on nitrated ECM recovered after adding the
inhibitors. The viable gated population, after the addition of cell death inhibitors, is graphically
depicted for the nitration and glycation modifications in Figure 3.28. Figure 3.28A displays an
increase in cell viability of 16% for cas-3 (apoptosis inhibitor), and a 32% increase in cell
viability with nec-1 (necroptosis and necrosis inhibitor). These data suggest there are multiple
pathways when necrosis and necroptosis play a major role when ARPE-19 cells are plated with
nitrated ECM. This is of particular interest as nitrated ECM was used as a model for
inflammation and necrosis and necroptosis are pro-inflammatory cell death pathways. These
results further implicate the role inflammation may play in RPE cell death associated with AMD.
ARPE-19 cells plated on glycated ECM also increased in cell viability after adding the
inhibitors. Figure 3.28B displays the observed data of glycation after the addition of inhibitors,
which indicated a significant recovery occurred with all inhibitors.
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Figure 3.25: FACS data for cell death inhibition studies on nitration ECM modifications. (A-D)
Representative histograms depicting AnnexinV negative (viable) and AnnexinV positive
populations for each inhibitor added to a nitrated ECM experiment. The X-axis displays
Annexin-V Alexa 488 fluorescence intensity and the Y-axis displays cell counts. The values on
each histogram represent the cell % within the gated population labeled. The gray histogram is
+no inhibitor, the blue is +caspase-1 inhibitor, the green is +caspase-3 inhibitor, and the red is
+Necrostatin-1.
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Figure 3.26: FACS data for cell death inhibition studies. Images are representative quadrant data
showing one measurement for the nitration reaction experiment for each inhibitor. The same
parameters as described previously were used. The images are depicted as follows: (A) Nitration
modification + no inhibitor, (B) nitration modification + caspase-1 inhibitor, (C) nitration
modification + caspase-3 inhibitor and (D) nitration modification + Necrostatin-1. The
experiment was performed with a total of three measurements with similar results achieved.
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Figure 3.27: FACS data for cell death inhibition studies. Images are representative quadrant data
showing one measurement of the glycation ECM modification experiment for each inhibitor.
The same parameters as described previously were used. The images are depicted as follows: (A)
Glycation modification + no inhibitor, (B) glycation modification + caspase-1 inhibitor, (C)
glycation modification + caspase-3 inhibitor and (D) glycation modification + Necrostatin-1.
The experiment was performed with a total of three measurements with similar results achieved.
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Figure 3.28: Graphical representation of FACS cell death inhibitor data. Data displayed is the
viable cell population from quadrant 4. (A) Nitration modification results suggesting significant
increase in overall viability under apoptotic and non-apoptotic pathways. (B) Glycation
modification to ECM results suggesting overall significant increases in cell viability under all
conditions. All data is represented as means ± SD (n=3) and statistical analysis using Student’s
two tailed T-test. *p<0.005, **p<0.001, ***p<0.0001

The observed data depicted in figure 3.21B, indicated most of the cell death occurred in the 136
early apoptotic population. As expected, the greatest viability recovery was shown to occur with
the addition of cas-3 at a 61% increase. However, results suggested significant recovery with all
cell death inhibitors, consequently implicating an overlap of cell death pathways. It can be
hypothesized that when the ECM is modified via glycation, there is more than one pathway
involved with apoptosis as the main cell death mechanisms associated with RPE cell death and
AMD.
The inhibitors were also added to ARPE-19 cells plated on A2E and A2E+ BL modified
ECM. Figures 3.29A and 3.29C visually depict a cell density decrease from quadrant 2 to
quadrant 4 for ARPE-19 cells on A2E modified ECM with inhibitors. The flow cytometry gated
populations for the A2E +BL modifications when cell death inhibitors were added are displayed
in figure 3.30. In figures 3.30A and 3.30D, the cell density appears to have a large shift from
quadrant 2 to quadrant 4. Figure 3.31 graphically depicts the viable cell results from A2E
modifications with and without BL irradiation and addition of cell death inhibitors. A significant
cell death recovery was observed with the cas-3 and nec-1 for A2E modification (Figure 3.31A).
For A2E + BL, the most significant recovery (p<0.0001) occurred with nec-1. Altogether the
nec-1 inhibitors confirmed that necrosis occurs in ARPE-19 cell when exposed to A2E and A2E
+ BL modified ECM. Interestingly, A2E dark modification results indicated no significant
recovery with cas-1 while A2E +BL results indicated a 23% recovery with cas-1. These data
suggest that ARPE-19 cells undergo different cell death mechanisms when subjected to BL
irradiation. Specifically, A2E + BL ARPE-19 cells appeared to undergo pyroptosis as a cell
death mechanism where ARPE-19 cells plated with A2E (no BL and kept in the dark) did not.
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Figure 3.29: FACS data for cell death inhibition studies. Images are representative data showing
one measurement for the A2E modification experiment for each inhibitor. The same parameters
as described previously were used. The images are depicted as follows: (A) A2E modification +
no inhibitor, (B) A2E modification + caspase-1 inhibitor, (C) A2E modification + caspase-3
inhibitor and (D) A2E modification + Necrostatin-1. The experiment was performed with a total
of three measurements with similar results achieved
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Figure 3.30: FACS data for cell death inhibition studies. Images are representative data showing
one measurement of the A2E +BL modification experiment for each inhibitor. The same
parameters as described previously were used. The images are depicted as follows: (A) A2E +BL
modification + no inhibitor, (B) A2E +BL modification + caspase-1 inhibitor, (C) A2E +BL
modification + caspase-3 inhibitor and (D) A2E + BL modification + Necrostatin-1. The
experiments were performed with a total of three measurements with similar results achieved.
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Figure 3.31: Graphical representation of FACS data for cell death inhibition studies. Data shown
is the viable cell (Ann-/PI-) population. Each inhibitor condition was compared to the modified
cell viability with no inhibitor added. (A) A2E modification results indicated significant cell
viability increases under caspase-3 inhibition and non-apoptotic pathway inhibition. (B) A2E +
BL modification results suggest cell viability increases under all cell death inhibition tested. All
data is represented as means ± SD (n=3) and statistical analysis using Student’s two tailed T-test.
*p<0.05, **p<0.0005 and ***p<0.0001

Discussion
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Although RPE cell death is a well-established characteristic of AMD, the exact
mechanism of cell death remains unclear. These studies were aimed at understanding the
mechanism of cell death in order to investigate the progression of AMD. Posttranslational ECM
protein modifications that have been correlated with AMD were modeled in this study including
the following: glycation as a model for aging, nitration as a model for inflammation and A2E
with and without BL irradiation as a model for oxidative stress. In this study, we hypothesized
that RPE cell death is a result of overlapping cell death mechanisms between apoptosis, necrosis,
pyroptosis and necroptosis. We have shown that through MTT assay, glycation and nitration
ECM modifications have a decrease in metabolic activity and proliferation; however, differ
widely in the cell viability studies. Non-enzymatic nitration of the ECM indicated non-viable
ARPE-19 cells were in early apoptosis and late apoptosis/necrosis. Inhibition cell viability
studies showed significant ARPE-19 cell death recovery for nitrated ECM with cas-3 and nec-1
inhibitors. Non-enzymatic glycation, via glycolaldehyde, ECM modification indicated nonviable ARPE-19 cells were in early apoptosis; however, when cell death inhibitors were added, a
significant recovery occurred with every inhibitor. Modifications to the ECM mediated by A2E
and blue light irradiated A2E indicated most of the non-viable ARPE-19 cells were in a state of
late apoptosis and necrosis. When inhibitors were added to A2E dark ECM modifications,
significant ARPE-19 cell death recovery occurred with cas-3 and nec-1. In contrast, A2E
modifications coupled with blue light irradiation results indicated a significant cell death
recovery with all inhibitors.
Fibronectin and laminin are two proteins essential to the functions of the BM.
Specifically, fibronectin, found in the inner collagenous layers of the BM, has been hypothesized

to have particular significance in proper RPE cell attachment to the BM (Gullapalli, Sugino, 141
Van Patten, Shah, & Zarbin, 2004; Tezel, Del Priore, Priore, & DelPriore, 1997). It has been
demonstrated that the fibronectin modifications may significantly occur in the α5β1 binding
region of fibronectin (M. Thao, 2014; M. T. Thao et al., 2014). Modifications to this region have
the potential to drastically affect the relationship between the BM and the RPE, including
hindering RPE cell attachment and function. In this study, FN was modified by non-enzymatic
glycation, non-enzymatic nitration, BL irradiated A2E and A2E. While the results for cell
proliferation suggested a significant decrease in mitochondrial function of ARPE-19 cells seeded
on glycation, A2E dark and A2E + BL modifications, the cell viability results did not depict a
significant decrease in viability in any of the modifications. MTT requires a much smaller
number of cells to be seeded compared to the flow cytometry procedures, potentially allowing
the viable cells to overshadow any non-viable cells that may be accruing. Thus, this study was
revised by modifying RPE derived ECMs using the same disease models to further explore cell
death mechanisms.
Nitration and glycation of the ECM have been studied as models for aging and disease,
specifically AMD (Crabb et al., 2002; Gillery & Jaisson, 2014; Glenn et al., 2009a; Gow,
Farkouh, Munson, Posencheg, & Ischiropoulos, 2004; Murdaugh et al., 2011; Nagai et al., 2000;
Paik et al., 1997; Sell & Monnir, 1989; Z. Wang, Paik, Del Priore, Burch III Scholar, & Gaillard,
2005). Our findings agree with several groups of which have reported data that strongly support
co-regulation of necroptosis and apoptosis, however, this is the first study that has associated
these mechanisms with RPE cell death (Vandenabeele, Galluzzi, Vanden Berghe, & Kroemer,
2010; W. Zhou & Yuan, 2014). Inhibition cell viability studies showed significant recovery for
nitration with cas-3 and nec-1 inhibitors. This combination of recovery from cas-3 and nec-1

suggest that there may be a dual-programmed cell death pathway in inflammatory conditions 142
and can be implicated as a primary influence for the progression of AMD. This suggested that
the cell death mechanism may not be exclusively apoptosis, as previously reported, but a coregulation between apoptosis and necroptosis (Grimm et al., 2001; J. R. Sparrow & Cai, 2001;
Stress et al., 2014; Suter et al., 2000).
There was significant recovery observed for every inhibitor added to the samples with
glycated ECM where the recovery after the addition of the caspase-1 inhibitor was of particular
interest. These results suggest that pyroptosis may be involved with the advanced initiation of
pro-inflammatory factors. A reason for such an observation is the degree of glycation as it
increases with age. Accumulation of AGEs have been studied in association with negative effects
on BM function (Glenn et al., 2009; Nita et al., 2014; Schutt et al., 2003); however, there has not
been a study to date to directly investigate the relationship between extensive glycation of the
ECM and specific RPE cell death mechanisms to this extent. Additional studies where various
degrees of glycation should be done to further investigate the role of pyroptosis.
We have previously investigated A2E and BL irradiated A2E BM protein modifications
(Murdaugh et al., 2009b; M. T. Thao et al., 2014; Z. Wang et al., 2005); however, the effect
these modifications have on RPE cells has not been studied. The results of the current study
indicated a significant decrease in viability when modifying RPE-derived ECM with A2E and
BL irradiated A2E. Previous studies have shown A2E has toxic effects when fed to cells with
and without BL causing RPE cells to undergo apoptosis (Grimm et al., 2001; J. R. Sparrow &
Cai, 2001). In contrast, other studies have indicated that oxidative stress causes RPE cell death
via necrosis (Hanus et al., 2013). Our results indicated a significant increase in late apoptotic and
necrotic cells when modifying ECM with A2E. The recovery of cell viability observed in the

inhibition studies indicated neither necrosis nor apoptosis as the primary cell death
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mechanism, but an overlap of these cell death pathways with the addition of necroptosis. It has
been suggested that BL contributes to oxidative stress (King, Kent, & Bomser, 2005). Dorey et.
al. described similar results where BL exposure reduced RPE cell proliferation (C K Dorey,
Delori, & Akeo, 1990), and Kuse et. al reported damaging effects of BL exposure to
photoreceptors (Kuse et al., 2015). Our results suggested A2E mediated blue light modifications
to ECM proteins are initiating pro-inflammatory cell death pathways including pyroptosis and
necroptosis. The current study suggests the posttranslational modifications of ECM proteins from
A2E + BL are significantly inducing ARPE-19 cell death. This could be due to the highly
reactive species that are produced under blue light irradiation of A2E. This further supports the
hypothesis that A2E coupled with blue light exposure may be more deleterious to RPE cells than
A2E, and these differences may be initiating pyroptosis and necroptosis. Both of which are proinflammatory cell death mechanisms. Overall, these results support the hypothesis that AMD is a
multifaceted disease while providing a keen insight into the clinical characteristic of RPE cell
death that has not been done to this extent in previous studies.
Understanding the cell death mechanisms that are occurring as a result of the
current disease models studied are essential in further understanding the pathogenesis of
AMD. While a general understanding of disease characteristics are known, there remains a
huge deficit in the knowledge of how and why these AMD characteristics are occurring.
The current study expands on the foundation of basic information required for further
examining AMD. It is important to note that these ECM findings and following discussions
are based off of three measurements obtained for one experiment. In order to confirm
these results, new ECMs seeded from newly confluent cells would be required. However,

the current results are both promising and exciting to allow these experiments to be
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expanded upon and repeated. Expanding these studies individually can aid in
understanding the biochemical changes that occur in the retina when AMD begins and as it
progresses. Nevertheless, there are several more factors that can affect AMD outside of
RPE cell death that should be considered as the foundation continues to be built. These
factors can include the characteristic cellular waste that builds up in different layers of the
retina. Specifically, examining the potential impact retinal lipofuscin build-up has on the
biochemistry of the retina and any valuable information this cellular waste can give. This
investigation is the focus that is discussed in the next chapter of this work.

CHAPTER 4
FURTHER ELUCIDATION OF HUMAN LIPOFUSCIN IN RELATION TO AGE-RELATED
MACULAR DEGENERATION

Introduction
The leading cause of irreversible blindness in developed countries is age-related macular
degeneration (AMD). Approximately 8 million Americans are reported as being affected by the
early stages of AMD; a diagnosis that puts them at a higher risk for developing more advanced
stages of AMD (Friedman et al., 2004; Jonas, 2014; B. E. K. Klein & Klein, 2009; NEI, 2016).
The National Eye Institute projects that the cases of advanced AMD in the United States will
more than double from year 2010 to year 2050 (figure 1.1). Globally it is estimated the number
of AMD cases will reach 196 million by the year 2020 (Jonas, 2014).
The disease is commonly categorized as either early or advanced stage AMD. Advanced
AMD can be classified into two different types: non exudative (dry) AMD and exudative (wet)
AMD (Coleman et al., 2008; De Jong, 2006). Dry AMD is characterized by drusen, distinct
pigmented granules, near the fovea causing gaps in the patient’s vision. Wet AMD is
characterized by the abnormal growth of blood vessels that leak into the retinal layers at the back
of the eye. Vision impairment begins rapidly, and as wet AMD progresses additional

hemorrhaging, scarring and permanent vision loss can occur (Binder & Falkner-Radler,
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2008; De Jong, 2006). It has been reported that patients can show signs of wet AMD, dry AMD
or both. In addition, some patients may experience wet AMD in one eye and dry AMD in the
other. This is consistent with the argument that wet and dry AMD may be two different diseases.
Diabetic retinopathy (DR) is one of the leading causes for new cases of legal blindness in
the United States. An estimated 2.9 million Americans have been diagnosed with diabetic
retinopathy. DR is classified in two forms as non-proliferative and proliferative (Akpek & Smith,
2013). Proliferative diabetic retinopathy (PDR) is the more severe type that is accompanied with
vision loss. PDR is clinically marked by proliferation of new retinal blood vessels that can cause
hemorrhaging into the vitreous cavity and can eventually lead to retinal detachment (Akpek &
Smith, 2013; T. Kim et al., 2007).
Many risk factors have been correlated with the onset and progression of AMD and DR
which include age, gender, race, oxidative stress and inflammation (figure 4.1). One major risk
factor is the build-up of lipofuscin. While the accumulation of lipofuscin is a common sign of
cellular aging, it is the increased accumulation of lipofuscin in the retinal pigment epithelium
(RPE) that is related to photoreceptor cell death and thought to be one of the leading causes of
AMD (see figure 1.7). Human retinal lipofuscin is a brown-yellow pigment that is
autofluorescent and composed of a highly complex mixture of lipids, proteins, vision cycle
byproducts and oxidized polyunsaturated fatty acids. The accumulation of lipofuscin is not only
associated with AMD, but also Best’s macular dystrophy and Stargardt’s disease. It has been
indicated that lipofuscin may be involved in disease pathogenesis through interference of normal
RPE function including inhibition of lysosomal degradation and reduction of antioxidant
capabilities (Schutt et al., 2003).
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Figure 4.1: Risk factors of AMD indicating the disease is multifactorial (Nowak, 2006).

Additionally, due to the RPE exocytosis behavior, it is believed RPE lipofuscin assists in the 148
formation of drusen in the BM (Crabb, 2014; Crabb et al., 2002). Although there has been some
success in the elucidation of human retinal lipofuscin components, it continues to be an active
area of study due to the complexity of the composition.
Posttranslational modifications of protein occurring both enzymatically and nonenzymatically are a sign of cellular aging and the deregulation of such has been associated with
age-related diseases. Modifications to proteins are known to impact the structure and function of
proteins. Common posttranslational modifications associated with age-related disease include
the following: oxidation, nitration, acetylation and glycosylation (Santos & Lindner, 2017).
Common protein residues that are subject to posttranslational modification include arginine and
lysine. These are of particular biological importance as lysine and arginine are essential amino
acids responsible for protein synthesis, antibodies, enzymes and hormones. Furthermore,
arginine in particular has been shown to be a precursor for several vital compounds in mammals
including urea, creatine, proline, glutamate and agmatine (Morris, 2006). Modifications to these
amino acids are thought to prevent normal cellular homeostasis by interfering with cellular
metabolism. Evidence of posttranslational modification found in RPE lipofuscin extracted from
diseased tissue can assist in understanding the age-related changes that occur with retinal disease
and lead to a more complete understanding of the pathogenesis of retinal disease.
Strong evidence has supported that there is a correlation between inflammation and
AMD. The activation of iNOS, the presence of peroxynitrite, nitrite and nitric oxide have been
investigated in relation to AMD. A biomarker of iNOS activity, 3-nitrotyrosine (3NT), has been
extensively studied as a non-enzymatic posttranslational modification in the presence of
peroxynitrite or nitrite ion. The biological formation of 3NT is depicted in figure 4.2.
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Figure 4.2: Schematic indicated different non-enzymatic pathways 3-nitrotyrosine formation.

Previously, the presence of 3NT has been verified in BM tissue associated with AMD
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(Murdaugh et al., 2010). Citrullination and carbamylation posttranslational modifications of
proteins have been implicated in many age-related diseases, including cancer autoimmune
diseases, atherosclerosis, kidney disease and inflammation (Pruijn, 2015). The biomarker Lhomocitrulline has been correlated with chronic inflammatory conditions such as rheumatoid
arthritis and is a product of non-enzymatic carbamylation of L-lysine (Gillery & Jaisson, 2014;
Pruijn, 2015). L-citrulline has been associated with cell death and inflammation and has been
shown to be a byproduct of iNOS activation with L-arginine acting as a precursor (Hallemeesch,
Lamers, & Deutz, 2002; Pruijn, 2015). Figure 4.3 displays a general schematic of the formation
of L-homocitrulline and L-citrulline. This work aims to identify these specific inflammatory
biomarkers in lipofuscin extracts obtained from human donor tissue where patients were
diagnosed with wet AMD, dry AMD or DR. The investigation includes identifying potential
biomarkers in association with enzymatic and non-enzymatic posttranslational modifications.
Identifying molecules in retinal lipofuscin that have previously been associated with
inflammation can aid in understanding the role inflammation plays in the pathogenesis of AMD.
Oxidation and inflammation in tissue are often related and the terms used interchangeably
when discussing human disease. This work differentiates the two by looking at specific
molecules that can be correlated to photooxidative stress. These molecules are identified as
potential stimuli for oxidative stress in the retina. Oxidative stress is a key factor in retinal
deterioration because the retina is one of the most highly oxygenated tissues in the human body.
A2E is a widely studied fluorophore commonly found in RPE lipofuscin and is thought to be a
contributing factor for oxidative stress in the retina.
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Figure 4.3: General schematic of L-citrulline and L-homocitrulline formation.

It has been reported that A2E has the ability to initiate free radical reactions and produce bis- 152
furanoid oxide compounds through photolysis. Further studies have shown formation of aldehyde
and ketone derivatives of A2E through photooxidation; these substances tend to be very reactive.
The process of A2E undergoing auto-oxidation is very significant in understanding the pathology
of AMD among other retinal disorders. While A2E modifications to proteins in the BM have
been studied, the detection of lysine and arginine modifications in RPE lipofuscin associated
with specific retinal disease has not been explored. The identification of posttranslational
modifications via oxidized A2E can be representative of the toxicity A2E has on not only BM
proteins, but also RPE and photoreceptor proteins. One aim of this project was to determine the
presence of these highly reactive photooxidation products in lipofuscin extracted from donor
tissue where the donor had been diagnosed with wet or dry AMD.
In addition to the oxidative stress of lipofuscin and the photooxidation of A2E, advanced
glycation end products (AGEs) are also thought to cause oxidative stress in the retina. One of
the most significant risk factors for AMD is aging. AGEs are mixtures of proteins that have been
glycated and oxidized after exposure to reactive aldehydes such as glucose, methylgloxal and
glyoxal. Studies have shown that AGEs advance the progression of age-associated disease by
endocytotic uptake and degradation, induction of cytokines and growth factors (Nagai et al.,
2000; Vlassara et al., 1994). These biological responses have been linked to the impairment of
structure and function of essential proteins.
AGE modification to the BM have been identified, particularly collagen cross-linking
adducts of glycolaldehyde. AGEs such as Nε-carboxymethyllysine (CML), as Nεcarboxyethyllysine (CEL) and pentosidine have been extensively studied as BM modifications
and linked to RPE detachments and cell death (Duran-Jimenez et al., 2009; Glenn et al., 2009;

Handa et al., 2016; Karachalias et al., 2003; Nagai et al., 2000; Sell & Monnir, 1989).
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Studies of drusen have also revealed AGE modification accumulation in the BM (Crabb, 2014;
Crabb et al., 2002). A proteomic study conducted by Schutt et. al. detected AGE modified
proteins in RPE lipofuscin (Schutt et al., 2003). Drusen is believed to contain components of
RPE lipofuscin where RPE cells release the molecular waste into the BM (Mazzitello et al.,
2009; Mullins et al., 2000). The BM is a highly collagenous tissue; thus, pentosidine, which is
specifically associated with collagen cross-linking, has been detected as an AGE present in
drusen originating in the BM. (Crabb, 2014; Handa et al., 2016; Ni et al., 2009). Pentosidine is a
glucose-mediated cross-link formed between a modified lysine residue and arginine. The
accumulation of pentosidine has been associated with age-related changes in vivo (Kerkeni et al.,
2013; Sell & Monnir, 1989). Both CML and pentosidine have been indicated as biomarkers for
age-related diseases, specifically diabetes, and as a precursor for microvascular complications
(Kerkeni et al., 2013). To date, no studies have indicated specific drusen markers present in RPE
lipofuscin. Detecting AGEs in RPE lipofuscin that have previously been reported to be specific
to BM may suggest RPE cells excrete molecules that have been shown to have deleterious
effects to the ECM. These molecules could further hinder the molecular function of the RPE and
BM.
The purpose of this work is to investigate human retinal lipofuscin organic soluble
extracts to further interpret structures associated with oxidative stress, inflammation and aging.
While the previous chapter focused on modeling disease to investigate a particular characteristic
(cell death) of AMD, this work uses human donor tissue to explore AMD from an alternative
angle. This work focuses on understanding the pathogenesis and progression of AMD through
the characterization of human retinal lipofuscin. To achieve this, this project further aims to

identify differences, if any, in composition of lipofuscin extracted from donor tissue obtained154
from donors that had been diagnosed with wet AMD, dry AMD or DR.
Results
In order to study the RPE lipofuscin composition associated with retinal disease, donor
globes were obtained from Eversight where they were dissected within 24 hours post mortem.
Donor eyes were obtained from patients that had been diagnosed with wet AMD, dry AMD, DR
or no disease diagnoses. Age-matched donors and young-age donors were obtained as controls.
The organic soluble lipofuscin extracts were compared using LC/MS as described in chapter 2.
Table 2.1 displays the donor information from the tissues used in this work. The medical history
of the patient can indicate additional differences in cellular waste build-up. For example, a
patient with a history of smoking may have particular components associated with inflammation
in their tissue compared to a patient without such a history. Therefore, it was important to note
any such relevant conditions to rule out any potential false-positive components identified. As
such, relevant medical history is reported in table 2.1. Samples are named and referred to in this
work in reference to the ocular disease the donor was diagnosed with. These samples are
identified as follows: wet AMD, dry AMD, DR, young-aged no ocular disorder (NODY) and
age-matched no ocular disorder (NODAM).
As a control and using HPLC to separate lipofuscin components based off of the
hydrophobicity of the molecules, the total ion current (TIC) chromatograms were obtained from
young no ocular disorder (NODY) and age-matched no ocular disorder (NODAM) samples were
compared (figure 4.4). The TICs indicated some differences in the composition, particularly at
the retention time range of 60-100 minutes. Figure 4.5 displays TIC comparisons for extracts

obtained from donors diagnosed with wet AMD, dry AMD and NODAM The most
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pronounced differences in the TICs are the retention time ranges from 10-30 minutes and 55-85
minutes. These differences in chromatograms were further analyzed by the mass spectra and
MSMS of the parent ion. These results indicated the masses correspond to compounds related to
inflammation and AGEs in the 10-30 minute retention times (referred to as group I), and
compounds related to A2E and A2E-derived products in the 55-85 minute retention times
(referred to as group II). Both AGEs and A2E derived products have absorbance footprints. The
PDA chromatograms were investigated to identify if the identified groups in the TIC
chromatograms also had absorbance characteristics. The corresponding PDA data are displayed
in figure 4.6. The PDA data for the wet AMD samples indicated several absorbance peaks
prevalent at retention times from 55-85 minutes (figure 4.6). In contrast, the data for the dry
AMD samples indicated several absorbance peaks prevalent at retention times from 10-30
minutes. Similarities in the NODAM TICs and dry AMD TICs were observed. These similarities
were also evident in the PDA total scans. The TICs comparing DR, Wet AMD and NODAM
samples are displayed in figure 4.7. While the ocular diseases of DR and wet AMD both have the
characteristic of choroidal neovascularization, the TIC data indicated few similarities between
the compositions of lipofuscin extracts from the DR and wet AMD samples. Figure 4.8 displays
the corresponding PDA total scans. The PDA data further supports the indication of limited
similarities between the DR and wet AMD samples. Specifically, the PDA data from DR
samples indicated absorbance peaks at earlier retention times. This earlier retention time range
observed in the PDA and TIC data of DR samples are within the retention time range identified
as group I and believed to be associated with inflammation biomarkers and AGEs.
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Figure 4.4: Total ion current chromatograms (TIC) obtained from organic soluble portion of
human retinal lipofuscin. Top: TIC from no ocular disorder (NOD) sample, age 39. Bottom:
NOD sample, age 73.
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Figure 4.5: TICs observed from organic soluble portion of human retinal lipofuscin. From top to
bottom: Lipofuscin from a wet AMD sample; lipofuscin from a dry AMD sample; Lipofuscin
from NOD sample, age 73.
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Figure 4.6: Corresponding photo diode array (PDA) total scan detection from organic soluble
lipofuscin. From top to bottom: PDA detection of wet AMD sample; PDA detection of dry
AMD sample; PDA of NOD sample, age 73.
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Figure 4.7: TICs observed from organic soluble portion of human retinal lipofuscin. From top to
bottom: Lipofuscin from diabetic retinopathy (DR) sample; lipofuscin from wet AMD sample;
Lipofuscin from NOD sample, age 73.
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Figure 4.8: Corresponding PDA total scan detection from organic soluble lipofuscin. From top
to bottom: PDA detection of DR sample; PDA detection of wet AMD sample; PDA of NOD
sample, age 73.

Further comparisons were done using XCMS Online (XCMS). XCMS Online is a
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web-based data analysis software intended for the processing of LC/MS data of untargeted
metabolomics. XCMS data analysis was performed for data obtained from a Q-Exactive-MS.
XCMS analysis of the sample sets allowed for a direct comparison between two sample types.
Comparisons of the following data sets were processed: Wet AMD vs. NODY, wet AMD vs.
NODAM, dry AMD vs. NODY, dry AMD vs. NODAM, DR vs. NODY, DR vs. NODAM, wet AMD
vs. dry AMD, Wet AMD vs. DR and DR vs. dry AMD. Data tables and graphical interpretations
can be pulled from the XCMS analysis software. Information obtained for particular features
include fold change, p-value, m/z, intensity, retention time and metabolic database hits. This
information can be filtered according to any of these parameters. In order to determine the most
significant features, a first pass analysis using XCMS software was done where filtering for
features that had p-values less than 0.01 and intensities greater than 1.0 x 106. This first pass
analysis filtering gave 965 features for the wet AMD vs. dry AMD comparative data and 1005
features for the wet AMD vs. DR comparative data. Although the first pass analysis still
contained a sizeable amount of significant features, the trend of two main groups, specified in the
TIC data, of retention times remained constant.
Lipofuscin is a complex mixture; thus, further filtering of the data was required for the
purpose of identifying features that can be used to understand the pathogenesis, the origin or
biomarkers of ocular disease. This additional filtering was done manually. In order to further
filter molecules of interest, each set of data was compared to NODAM and NODY samples.
Components that were observed in both the disease samples and no ocular disorder samples were
subtracted out of the wet AMD, dry AMD and DR data sets to depict the m/z that were specific
to each sample. The intensity, m/z and p-values were obtained from the XCMS software for

these features determined to be specific to the dry AMD, wet AMD or DR samples.
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Analyzing the ratios of intensity of particular m/z values and plotting it with the p-value can
obtain visual comparisons of these data known as a volcano plot. Figure 4.9 portrays a
representation of a volcano plot obtained from this analysis. The volcano plot is useful in further
filtering and displaying two sets of data and was done for each data comparison. These filtering
and display techniques were used to further identify components of particular interest. The
technique proved useful in significantly reducing the number of features that were specific to a
particular sample. Some of these components were further investigated using tandem mass
spectrometry.

Evidence of Inflammatory Biomarkers in Human Retinal Lipofuscin Extracts
Inflammation has been strongly correlated with AMD. A series of inflammation
biomarkers, including 3-nitrotyrosine, homocitrulline, citrulline and nitro-A2E were investigated
to see, if any, were specific to a particular retinal disease (figure 4.10). Lipofuscin extracts were
subjected to LCMS using a Q-Exactive MS and MSMS spectrums were examined. Mass-tocharge ratios of 190, 176, 227 and 637 were identified as significant components from XCMS
analysis and further analyzed. These masses correspond to homocitrulline, citrulline, 3NT and
nitro-A2E respectively. 3NT is stable under acid hydrolysis and has previously been identified in
human BM extracts. Nitro-A2E has been shown to be present in BM tissue from donors
diagnosed with AMD (Murdaugh et al., 2010). This study aimed to investigate these molecules
as being present in lipofuscin extracts that have been obtained from donor tissue diagnosed with
retinal disease.
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Figure 4.9: Volcano plot indicating significant identifiable components of wet AMD and dry
AMD extracts.
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3-Nitrotyrosine
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Figure 4.10: Molecular structures of inflammation biomarkers investigated in this work.

Selected-reaction Monitoring (SRM), a method in which a precursor ion is selected for
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detection and subsequent tandem mass spectrometry, using a Q-Exactive MS was performed on
lipofuscin extracts obtained from donor tissue where donors had been diagnosed with wet AMD,
dry AMD, DR, NODAM or NODY. SRM was employed as a way to detect nitro-A2E in retinal
disease lipofuscin samples. In order to verify the structures of these components the MSMS
spectra were analyzed. Table 4.1 displays the observed m/z of these potential biomarkers of
retinal disease. Results indicated these molecules were present in wet AMD, dry AMD or DR
diagnosed extracts but not in NODAM. When experimental conditions remain constant, retention
times (RT) are valuable in further verifying the presence of molecules between two or more
samples. The retention times reported in table 4.1 are indicative of the first group of molecules
discussed previously as inflammation and AGE biomarkers. MSMS was investigated to verify
the structures of these molecules and compared to previously reported cleavages.
Tandem MSMS is a useful analytical tool to identify compounds in a complex mixture,
such as RPE lipofuscin. The instrumental methods specific to the mass spectrometer used in this
study are outlined in Chapter 2. When analyzing the MSMS data for the purpose of elucidating a
potential structure, the parent ion is chosen from the list of detected analytes. The MSMS
spectrum shows fragments of the parent ion as a result of being subjected to the collision gas.
This process is described in detail in Chapter 2. The focus of this work is to investigate small
molecule analytes, that is, those that are less than 1000 m/z. Molecules with m/z less than 300
are of further interest in order to identify possible metabolites and biomarkers. Only fragments
that are charged (this work was performed using positive ion mode) are displayed in the MSMS
spectrum. This is taken into account when analyzing the MSMS fragments. There are several
factors that may impact the fragmentation of the parent ion. These factors include the relative
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bond strengths within the molecule and the stability of the resulting cation or radical.
Typically, the dominating fragmentation processes involving organic compounds are those

where a direct cleavage of bonds occur. Fragmentation of an ion occurs after the loss of a σ-, π-,
or n-electron. This is dependent upon the ionization energy of the fragment, where the fragment
with the lowest ionization energy will endure the loss of the electron. The retention of the charge
governs this fragmentation through what is known as the Stevenson’s Rule. Stevenson’s Rule
involves the assumption that the most probable fragmentation is the one that leaves the charge on
the fragment with the lowest ionization energy.
The process of verifying a structure using MSMS is very involved. When analyzing the
MSMS spectrum, components indicative of common losses are first identified; the loss of H2O is
an example of such common losses. Possible, or more favorable, sites of fragmentation in
association with Stevenson’s Rule are then investigated. Additionally, diagnostic cleavage sites
and fragments that can give information on the type of molecule are interpreted. For molecules
that have tandem mass spectra available in databases, the fragments from the database spectra
are compared to further identify a potential structure. When describing the MSMS data in this
work, these are the steps that were employed to identify possible cleavage sites.

Table 4.1: Observed m/z in lipofuscin extracts obtained from donors that had been diagnosed
with dry AMD, wet AMD, DR or NODAM.
m/z
227
176
190
637

Dry
AMD
ND
12.02
15.47
ND

Retention Time (min)
Wet
DR
AMD
5.71
6.68
12.28
11.98
ND
ND
80.02
ND

NOD
AM
ND
ND
ND
ND

Dry
AMD
ND
1.58E5
2.35E5
ND

Intensity
Wet
DR
AMD
3.87E5
4.53E6
1.09E5
1.73E5
ND
ND
1.95E5
ND

NOD
ND
ND
ND
ND

L-citrulline was expected to have a m/z of 176 [M+H]+ and is evidence of iNOS
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induced enzymatic posttranslational modification. The m/z 176 was observed in dry AMD, wet
AMD, and DR samples but not in NODAM samples. Figure 4.11 displays the MSMS of m/z 176
where the losses 35, 45 and 103 were identified. The corresponding proposed structure and
cleavages are also shown in figure 4.11. Further database cleavage matches from the Human
Metabolomic Database (HMDB) were identified as m/z 97, 131 and 141. The m/z 131 fragment
can be attributed to the loss of COOH (-45). The m/z 141 fragment may be attributed to the loss
of H2O and OH. These results could signify that during age-related retinal disease iNOS is active
in RPE cells resulting in posttranslational modifications to arginine residues. Further
investigation is required for further elucidation and verification of these molecules.
L-homocitrulline is evidence of non-enzymatic posttranslational modification to lysine
residues. It was expected to have m/z of 190 [M+H]+. Figure 4.12 displays the MSMS where the
losses of 45, 60, 72, 117 and 129 were identified. HMDB database cleavages were identified as
m/z 61, 73, and 130. The proposed structure and cleavages are also depicted in figure 4.12.
Table 4.2 depicts possible fragments associated with these losses. These results were repeatable
for three dry AMD samples. The data indicated carbamylation of lysine is evident in RPE cells in
patients diagnosed with dry AMD. Carbamylation has been associated with chronic
inflammatory diseases including atherosclerosis and rheumatoid arthritis; thereby, the presence
of m/z 190 may further suggest dry AMD as a chronic inflammatory condition. Additional
investigation of the prevalence of L-homocitrulline was implemented by adding an internal
standard of 0.1% ascorbic acid to a dry AMD diagnosed extract and a NODAM diagnosed extract.
The experimental gradient was adjusted by using acetonitrile in place of methanol.
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73

*(-H2O, -OH)

Figure 4.11: MSMS of m/z 176 with corresponding proposed structure and cleavages. The red
arrow is in reference to the loss of COOH. The green arrow is in reference to a database
fragment match.
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130

Figure 4.12: MSMS of m/z 190 with corresponding proposed structure and cleavages. The purple
arrow is in reference to the parent ion. See table 4.2 for additional fragment structure proposals.
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Table 4.2: Observed m/z fragments and proposed structures for parent ion 190. Masses of
proposed structures are given as nominal mass.

Observed m/z and proposed structures from MSMS L-Homocitrulline

130

118

73

61

XCMS analysis indicated the NODAM had an observed m/z of 190 with a retention time of
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19.90 minutes and the dry AMD sample had an observed m/z 190 with a retention time of 19.30
minutes. The structure was believed to be, through MSMS analysis, L-homocitrulline.
While L-homocitrulline was detectable when using acetonitrile in both extracts, using the
internal standard, it was determined the molecule was 25 times more prevalent in the dry AMD
diagnosed extract. The increased prevalence further indicated dry AMD is a chronic
inflammatory condition where L-homocitrulline, with further verification of the molecule, could
be used as a biomarker for dry AMD.
3-nitrotyrosine has been extensively studied as a biomarker for inflammation and was
expected to have a m/z of 227 [M+H]+. Figure 4.13 displays the MSMS of m/z 227 where
fragments 91, 105, 109, 209, 165 and 151 were identified. The fragment 209 may be associated
with the loss of H2O. Table 4.3 shows the proposed structures for these fragments. The nitration
of tyrosine in all retinal disease tissue samples may indicate the presence of nonenzymatic
nitration precursors, including peroxynitrite, nitrite and nitric oxide. All of which can be
indicative of inflammation where a localized increase of these molecules can modify protein
residues.
Figure 4.14 depicts the verification of nitro-A2E in wet AMD samples. Figure 4.14A
displays the SRM TIC for m/z 637 where monitoring occurred at 637 ± 4 m/z. A peak at RT
80.02 minutes was determined to be the 637-containing peak. Figure 4.14B displays the MS at
RT 80.02 minutes. This retention time falls within the group II of the TIC data where the
hydrophobicity is expected to match that of A2E and A2E derived products. Figure 4.14C shows
a box-and-whisker plot obtained from XCMS analysis of the wet AMD sample versus the dry
AMD sample.
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*

91
109

Figure 4.13: MSMS of m/z 227 indicating fragments identified with corresponding proposed
structure. The purple arrow is in reference to the parent ion. Additional fragments and structures
are summarized in table 4.3. * Refers to loss of water.

173
Table 4.3: Observed m/z fragments and proposed structures for parent ion 227.

Observed m/z and proposed structures from MSMS 3-NT

174
A

B

C

Figure 4.14: Verification of nitro-A2E presence in wet AMD samples. (A) SRM TIC of m/z 637
with monitoring m/z ± 4. (B) MS spectrum at RT 80.02. (C) Box-and-whisker plot obtained from
XCMS analysis.

The “box” in the box-and whisker plot indicates the range in intensity for each sample and
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the “whisker” represents the error. The error was calculated from three consecutive LCMS runs
using a Q-Exactive MS. These results suggest the m/z 637 is more prevalent in wet AMD
samples. Figure 4.15 displays the MSMS of m/z 637 where losses of the NO2 group, 182, 250,
272 and 412 were identified. Figure 4.16 depicts the proposed structure with cleavages further
verifying the molecule to be nitro-A2E. These results indicated there is a potential for activation
of iNOS due to the presence of L-citrulline in the wet AMD, dry AMD and DR samples. The
presence of L-homocitrulline in dry AMD samples suggested non-enzymatic posttranslational
modifications associated with chronic inflammation might be occurring. Results suggested nitroA2E was prevalent in the wet AMD sample. Previous studies have indicated a higher prevalence
of nitro-A2E in BM compared to lipofuscin (Murdaugh et al., 2010). Overall, these results
support the hypothesis that wet AMD and dry AMD may have two different pathogeneses where
the origin of the disease progression differs. With further exploration, these molecules may be
crucial in determining disease biomarkers. Further elucidation of the molecules is imperative to
make a conclusive statement on the identity of these molecules.

AGE Prevalence in Human RPE Lipofuscin Extracts
Several studies have reported AGE presence in both lipofuscin and drusen deposits
associated with AMD and DR. Proteomic studies of drusen deposits have indicated the presence
of lipofuscin-specific components (An et al., 2006; Crabb, 2014; Crabb et al., 2002; Gregory S.
Hageman et al., 2001). This suggests the RPE are capable of removing some of the waste
product build-up from the lysosomes to the BM and may be partially responsible for drusen
deposits.

176

Figure 4.15: MSMS of m/z 637 indicating fragments identified. The color references the colorcoded corresponding cleavages of the proposed structure. The purple is in reference to the parent
ion.
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592

Figure 4.16: Proposed molecular structure and cleavages of m/z 637. Color-coding is dependent
on the cleavages. Black represents a single cleavage while the blue indicate more than one
cleavage to produce a specific fragment.

The investigations of two AGEs that have been extensively studied in drusen were
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investigated as possible components of lipofuscin. Pentosidine (m/z 379) was of particular
interest as it is associated with collagen crosslinking and been exclusively detected in tissues that
are high in collagen. Carboxymethyl lysine (CML) (m/z 205) was also chosen to investigate due
to the proteomic studies of drusen indicating the presence of CML protein adducts in BM.
A total of eight human retinal lipofuscin extracts were subjected to LC-MS/MS for the
presence of these exclusively BM AGE accumulations. In addition to comparing the
fragmentation pattern to previously published work, the MSMS spectra were analyzed using the
same methods as previously described. Table 4.4 displays the RT for each of the lipofuscin
extracts investigated. These retention times are within the predicted group I retention times as
described in the TIC results, further suggesting the hydrophobicity of these molecules fall in line
with AGEs and inflammatory biomarkers as expected.

Table 4.4: Retention time of observed m/z 205 and 379 from lipofuscin samples.
Lipofuscin
samples
L1
L2
L3
L4
L5
L6
L7
L8

Retention Time
(min)
m/z 205 m/z 379
8.70
26.50
8.71
26.42
8.57
26.50
8.92
25.10
8.67
26.51
8.00
25.62
ND
27.12
ND
ND

The m/z 379 was detected in all samples with the exception of the NODY sample.
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Figure 4.17 displays a representative MSMS for the m/z 379 where the highlighted fragments
were identified in conjunction with previously reported cleavages (Sell & Monnir, 1989). Figure
4.17 also depicts the proposed structure of m/z 379. These results indicated the molecule is likely
pentosidine. The m/z 205 was detected in all but two samples. These two samples were
diagnosed as no ocular disorder, from one donor of age 44 years and another donor of age 65
years. Figure 4.18 displays the MSMS of m/z 205 and the corresponding structure. These results
indicated the component with m/z is likely CML. CML has been shown to be a general
biomarker for oxidative stress in addition to age-related disease. The presence of CML in
samples obtained from donors diagnosed with ocular disease, but not in an age-matched donor
further support ocular disease is, in part, a result of oxidative stress in the retina.
Overall these results indicated the presence of AGEs that have been identified as
components of drusen deposits. To date, there have been no studies indicating the presence of
pentosidine in retinal lipofuscin. The formation of the molecule has been shown to be exclusive
to collagen-containing tissues. These results indicated the presence of pentosidine in the cellular
waste accumulation of the RPE where the formation occurs in the RPE rather than the BM. RPE
have been shown to be phagocytic and transport molecules to the BM. These results further
suggest that the RPE may be contributing to drusen deposits in addition to the transportation of
deleterious molecules from the RPE to the BM, which could result in increased oxidative stress.
Additional studies to further verify the presence of these molecules and continued
characterization of the structures are of interest.
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Figure 4.17: MSMS of m/z 379 and corresponding structure. Black represents a single cleavage
while the blue, red, green, gold and orange indicate more than one cleavage to produce a specific
fragment. The purple arrow is in reference to the parent ion.
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Figure 4.18: MSMS of m/z 205 and corresponding structure. The purple arrow is in reference to
the parent ion. Color-coding is dependent on cleavages. Black refers to one cleavage and blue
refers to multiple cleavages to produce the fragment.

A2E and A2E-Derived Components Observed in Lipofuscin Extracts
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A2E is derived as a visual cycle waste product and one of the components that has been
identified in human retinal lipofuscin. A2E readily oxidizes into a bis-furanoid oxide similar to
β-carotene (Baldas, Porter, Cholnoky, Szabolos, & Weedon, 1996; J. Dillon et al., 2004). Figure
4.19A shows the mechanism of acid catalyzed rearrangement of β-carotene 5,6-epoxide to the
5,8-furanoid oxide. A2E is thought to oxidize via a similar mechanism. The structures of A2E
and the corresponding oxidized A2E is shown in figure 4.19B. In order to determine if any
oxidative modifications via A2E were occurring, it was important to identify A2E and oxidized
A2E in these particular samples. Furthermore, it was of interest to determine if A2E is
preferentially prevalent in specific diseased-diagnosed donor tissue. In order to determine if A2E
and oxidized A2E were present in the samples, SRM using a Q-Exactive MS was performed on
wet AMD, dry AMD, DR, NODAM and NODY samples. Table 4.5 displays the detection of A2E
(m/z 592) and oxidized A2E (m/z 608). Both A2E and oxidized A2E were detected in all
extracts with the exception of NODY. The RT and intensity are listed in table 4.5 indicating the
retention time was comparable for all detections of m/z 592 and m/z 608. The expected
hydrophobicity along with previous studies are in agreement with these molecules being within
the group II TIC components predicted to be A2E and A2E derived products.

Table 4.5: Detection of A2E and oxidized A2E in human retinal lipofuscin extracts obtained 183
from donor tissue where the donors were diagnosed with dry AMD, wet AMD, DR, NODAM
or NODY (age 44).
A2E
Retention Time (min)
Intensity
& A2E
Wet
NOD NOD
Dry
Wet
NOD
NOD
Oxidized Dry
DR
DR
AMD AMD
AM
44
AMD AMD
AM
44
m/z
592
51.63 51.64 51.82 51.87 52.06 4.11E6 1.27E7 5.58E5 1.55E7 5.25E5
608
51.46 51.69 51.90 51.69 ND 1.87E7 8.94E6 3.46E6 6.30E7
ND

Figure 4.20 displays the representative SRM TICs for m/z 592 where SRM was monitored at 592
± 4 m/z. The TICs of wet AMD samples (figure 4.9A) and dry AMD samples (figure 4.9B)
indicated a sharp peak at a RT of approximately 52 minutes. Figure 4.21A and B shows the
comparisons of the mass spectra (MS) at RTs 51.64 minutes and 51.63 minutes, respectively.
The MS indicated the m/z observed is 592 for both further verifying the presence of A2E in wet
AMD and dry AMD samples. Additional examination of the tandem mass spectra (MSMS) was
done for each extract to further verify the m/z 592 was the molecule A2E. Figure 4.21C and D
show the MSMS indicated similar fragmentation patterns and correspond to A2E fragmentation
(figure 4.22). These results were similar in all extracts where m/z 592 was detected. It has been
previously shown that the concentration of A2E in retinal lipofuscin increases with age and
further increases with AMD (Murdaugh, 2010). The current results are indicative that A2E
presence in human retinal lipofuscin is not dependent on the type of AMD. However, these are
not quantitative results so the concentration of A2E cannot be established from these data.
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A

B

Figure 4.19: Mechanism and product of oxidation for retinal carotenoids. (A) Acid catalyzed
rearrangement of epoxide to furanoid oxide. (B) Oxidation of A2E to 5,8,5’, 8’-bis-furanoid
oxide of A2E (Baldas et al., 1996; J. Dillon et al., 2004).
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Figure 4.20: TICs from SRM using Q-Exactive MS. SRM was monitored for 592 ± 4 m/z. (A)
TIC from a wet AMD sample. (B) TIC from a dry AMD sample.
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Figure 4.21: Verification of A2E presence in human retinal lipofuscin extracts. (A) MS of m/z
592 at RT 51.64 from a wet AMD sample. (B) MS of m/z at RT 51.63 from a dry AMD sample.
(C) MSMS of m/z 592 from a wet AMD sample. (D) MSMS of m/z 592 from a dry AMD
sample.
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Figure 4.22: Molecular structure of A2E and its corresponding fragment pattern.

SRM was also performed for m/z 608 where the monitoring occurred at 608 ± 4 m/z. 188
Figure 4.23 shows the representative data for wet AMD samples. The SRM TIC indicated a
sharp peak at RT, 51.69 minutes (figure 4.23A). The MS at RT 51.69 minutes for the wet AMD
sample indicated the m/z of 608 is predominantly observed. The MSMS of the m/z 608 verified
the structure as being oxidized A2E (figures 4.23B and C). The molecular structure with the
corresponding fragmentation pattern of oxidized A2E is shown in figure 4.24. These results
were similar in all extracts where m/z 608 was detected. These results further indicated that
oxidized A2E is observed regardless of the type of AMD; however, this is not a quantitative
measurement.
To further investigate human retinal lipofuscin compositional differences in retinal
disease, photooxidized A2E-products were considered. Recent work by Ablonczy et. al. has
shown A2E may be less prevalent in the macular region compared to the periphery of the retina
(Ablonczy et al., 2013). A2E has been shown to photooxidize into highly reactive aldehydes and
ketones (Z. Wang et al., 2006). When A2E is photooxidized, the fluorescent footprint changes
causing the conjugation of the molecule to be broken. The reduced A2E prevalence observed by
Ablonczky et. al. could be due to the increased photooxidation of A2E in the macular region of
diseased tissue. This can be investigated through the observance of products derived from
aldehyde reactions with protein residues.
Previously, Wang et. al. described the oxidative products of photooxidized A2E. It was
found that these by-products of photooxidation result in reactive aldehydes (Z. Wang et al.,
2006). Previously, A2E derived aldehydes have been described as modifying BM proteins
preferentially at arginine and lysine sites.
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Figure 4.23: Verification of A2E presence in human retinal lipofuscin extracts. (A) SRM TIC
from a wet AMD sample. (B) MS from a wet AMD sample at RT 51.69. (C) MSMS of m/z 608
detected in a wet AMD sample. These results were comparable in all extracts where m/z 608
was detected.
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Figure 4.24: Molecular structure of oxidized A2E with corresponding fragmentation pattern.
Color-coding is dependent on the cleavages. Black represents a single cleavage while the red
and blue indicate more than one cleavage to produce a specific fragment. Additional cleavages
after furan cleavage are depicted in blue.

To investigate if any products of the A2E aldehydes + protein residue reactions, specifically 191
arginine and lysine, were present preferentially in disease samples, Q-Exactive mass
spectrometry was implemented and the MSMS spectra, as a product of high-energy collisional
dissociation (HCD), were analyzed. The MSMS was analyzed in the same fashion as outlined
previously. These aldehydes (shown in figure 4.25) were chosen specifically due to previously
reported observations of these m/z reacting with BM proteins and the implications of
posttranslational modifications to lysine and arginine. In these previous reported works, lysine
(K) and arginine (R) were proposed to undergo condensation reactions with the photooxidized
A2E aldehyde product. The proposed mechanisms are shown in figures 4.26-4.27. The
observed m/z believed to be a product of the amino acid and A2E reactions are listed in table 4.6.
The table indicates that all m/z reported were observed in the wet AMD samples. There was one
observed m/z for NODAM, two observed m/z for dry AMD samples and two observed m/z in DR
samples. Most of the observed m/z have RTs that are in group II as described above (figures 4.54.8) which is predicted to be A2E and A2E derived products due to the molecules higher
hydrophobicity. The observed m/z of 494, 534 and 666 are proposed to be a result of a lysine
condensation reaction and observed m/z of 588, 522, 562 and 578 are proposed to be a result of
an arginine condensation reaction (table 4.6). The MSMS of m/z 494 is displayed in figure 4.28
indicating the losses of 33, 77, 357 and 371 were identified. The m/z 494 was observed in wet
AMD and dry AMD samples. Figure 4.29 depicts the corresponding proposed structure and
cleavages of m/z 494 as a result of the reaction: [366 + K] – H2O. The MSMS of m/z 534 is
displayed in figure 4.30 indicating the losses of 31, 75, 157, 172 and 253 were identified. The
m/z 534 was observed in DR and wet AMD samples. Figure 4.31 depicts the corresponding
proposed structure and cleavages of m/z 534 as a result of the reaction: [406 +K] – H2O.
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Figure 4.25: Corresponding aldehydes of photooxidized A2E, photooxidized furan-A2E and 193
molecular structures previously reported by Wang et. al. that are considered in this work.

Figure 4.26: The proposed mechanism between A2E-derived aldehyde and lysine. The
mechanism is a condensation reaction where a loss of water is observed (as previously reported
in Thao et. al. 2014).
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Figure 4.27: The proposed mechanism between A2E-derived aldehyde and arginine. The
mechanism is a condensation reaction where a loss of water is observed (as previously reported
in Thao et. al 2014).
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Table 4.6: Observed m/z of aldehyde and either lysine or arginine reactions. Retention time and
intensity are listed for each sample investigated.

(Aldehyde)
+A.A
residue 18)
m/z
(432 + R)
588
(366 + R)
522
(406 + R)
562
(422 + R)
578
(366 + K)
494
(406 + K)
534
(488 + K)
616

Retention Time (min)
Dry
Wet
DR
NOD
AMD
AMD

Dry
AMD

Intensity
Wet
DR
AMD

52.08

52.18

ND

ND

2.31E4

7.85E4

ND

ND

ND

79.99

ND

79.97

ND

4.00E4

ND

3.01E4

ND

79.56

78.17

ND

ND

4.39E4

1.63E4

ND

ND

72.43

ND

ND

ND

5.00E4

ND

ND

16.70

15.64

ND

ND

1.47E6

2.92E6

ND

ND

ND

7.08

7.14

ND

ND

9.92E5

7.41E5

ND

ND

45.52

ND

ND

ND

2.14E7

ND

ND

NOD
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Figure 4.28: MSMS spectrum of m/z 494 as observed in wet AMD samples. The fragments
highlighted are indicative of the dissociation of m/z 494 and were identified according to the
proposed molecular structure. The color references the color-coded corresponding cleavages of
the proposed structure. The purple is in reference to the parent ion.
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Figure 4.29: Proposed structure of m/z 494 as a result of aldehyde 366 + K with cleavages
identified. Color-coding is dependent on the cleavages. Black represents a single cleavage while
the red, blue and green indicate more than one cleavage to the molecule in order to produce a
specific fragment.
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Figure 4.30: MSMS spectrum of m/z 534 as observed in wet AMD samples. The fragments
highlighted are indicative of the dissociation of m/z 534 and were identified according to the
proposed molecular structure. The color references the color-coded corresponding cleavages of
the proposed structure. The purple is in reference to the parent ion.
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Figure 4.31: Proposed structure of m/z 534 as a result of aldehyde 406 + K with cleavages
identified. Black represents a single cleavage while the red and blue indicate more than one
cleavage to the molecule in order to produce a specific fragment.

The MSMS of m/z 616 was observed in wet AMD samples and is displayed in figure 4.32
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indicating the losses of 191, 289, 345 and 481 were identified. Figure 4.33 depicts the
corresponding structure and cleavages of m/z 616 as a result of the reaction: [488 +K] – H2O.
The MSMS of m/z 588 is displayed in figure 4.34 indicating the losses of H2O, 117, 134, 171,
183, 415, 441 and 515 were identified. The m/z 588 was observed in wet AMD and dry AMD
samples. Figure 4.35 depicts the corresponding structure and cleavages of m/z 588 as a result of
the reaction: [432 +R] – H2O. The MSMS of m/z 522 is displayed in figure 4.36 indicating the
losses of 19, 61, 79, 222 and 249 were identified. The m/z 522 was observed in wet AMD and
NODAM samples. It is interesting to note this was the only aldehyde reaction product that was
observed in the NODAM sample. While the medical history for the donor did not indicate
anything of significance, the history that is provided is limited and can be dependent on the
donor. This observation of the m/z could indicate oxidative stress. Figure 4.37 depicts the
corresponding structure and cleavages of m/z 522 as a result of the reaction: [366 +R] – H2O.
The MSMS of m/z 562 is displayed in figure 4.38 indicating the losses of water, 136, 154, 277
and 289 were identified. The m/z 562 was observed in wet AMD and DR samples. Figure 4.39
depicts the proposed structure and cleavages of m/z 562 as a result of the reaction: [406 +R] –
H2O. The MSMS of m/z 578 is displayed in figure 4.40 indicating losses of H2O, 35, 166, 191,
253, 307 and 321 were identified. The m/z 578 was observed in the wet AMD sample. Figure
4.41 depicts the corresponding proposed structure and cleavages of m/z 578 as a result of the
reaction: [422 + R] – H2O.
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Figure 4.32: MSMS spectrum of m/z 616 as observed in wet AMD samples. The fragments
highlighted are indicative of the dissociation of m/z 616 and were identified according to the
proposed molecular structure. The color references the color-coded corresponding cleavages of
the proposed structure. The purple is in reference to the parent ion.
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Figure 4.33: Proposed structure of m/z 616 as a result of aldehyde 488 + K with cleavages
identified. Color-coding is dependent on the cleavages. Black represents a single cleavage while
the red, green, gold and blue indicate more than one cleavage to produce a specific fragment.
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Figure 4.34: MSMS spectrum of m/z 588 as observed in the wet AMD sample. The fragments
highlighted are indicative of the dissociation of m/z 588 and were identified according to the
proposed molecular structure. The color references the color-coded corresponding cleavages of
the proposed structure. The purple is in reference to the parent ion.
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Figure 4.35: Proposed structure of m/z 588 as a result of aldehyde 432 + R with cleavages
identified. Color-coding is dependent on the cleavages. Black represents a single cleavage while
the red and blue indicate more than one cleavage to produce a specific fragment.
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Figure 4.36: MSMS spectrum of m/z 522 as observed in wet AMD samples. The fragments
highlighted are indicative of the dissociation of m/z 522 and were identified according to the
proposed molecular structure. The color references the color-coded corresponding cleavages of
the proposed structure. The purple is in reference to the parent ion.
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Figure 4.37: Proposed structure of m/z 522 as a result of aldehyde 366 + R with cleavages
identified. Color-coding is dependent on the cleavages. Black represents a single cleavage while
the red, orange, green, gold and blue indicate more than one cleavage to produce a specific
fragment.
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Figure 4.38: MSMS spectrum of m/z 562 as observed in wet AMD samples. The fragments
highlighted are indicative of the dissociation of m/z 562 and were identified according to the
proposed molecular structure. The color references the color-coded corresponding cleavages of
the proposed structure. The purple is in reference to the parent ion. *[M-H]- H2O.
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Figure 4.39: Proposed structure of m/z 562 as a result of aldehyde 406 + R with cleavages
identified. Color-coding is dependent on the cleavages. Black represents a single cleavage while
the red, green and blue indicate more than one cleavage to produce a specific fragment.
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Figure 4.40: MSMS spectrum of m/z 578 as observed in wet AMD samples. The fragments
highlighted are indicative of the dissociation of m/z 578 and were identified according to the
proposed molecular structure. The color references the color-coded corresponding cleavages of
the proposed structure. The purple is in reference to the parent ion. *[M-H]-H2O.
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Figure 4.41: Proposed structure of m/z 578 as a result of aldehyde 422 + R with cleavages
identified. Color-coding is dependent on the cleavages. Black represents a single cleavage while
the red, green, gold, orange, cyan and blue indicate more than one cleavage to produce a specific
fragment.
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Overall, these results indicated that the aldehyde reactions with amino acid residues arginine and
lysine were preferential to the wet AMD samples. There were some indications where there was
m/z detection in both dry AMD and wet AMD samples (m/z 494 and 588). Two m/z were
observed in both wet AMD samples and DR samples included m/z 534 and 562.
These results do indicate a trend in that the wet AMD sample was the only sample where
aldehyde reactions originating from the photooxidation of 608 were observed. This is of
particular interest as oxidized A2E (m/z 608) was observed in every extract investigated that was
obtained from donor tissue diagnosed with an ocular disorder. These results indicated that there
is a build-up of oxidative products originating from A2E and oxidized A2E in retinal lipofuscin.
There does seem to be an increased effect for wet AMD samples. With further investigation and
elucidation of these molecules, these results could assist in understanding the origin and impact
of these oxidative by-products observed in the retinal lipofuscin.

Discussion
Human retinal lipofuscin was extracted from human donor eyes where the donors were
previously diagnosed with wet AMD, dry AMD or DR and examined to identify prevalent
components. A2E and oxidized A2E were shown to have no preferential accumulation in a
particular retinal disease. Oxidation products of A2E and oxidized-A2E were also investigated.
The proposed aldehydes resulting from photooxidation were chosen as they have been previously
shown to modify BM proteins (Murdaugh, 2010; M. T. Thao et al., 2014). Two trends were
indicated. The first trend was that all proposed products were observed in wet AMD samples.
A2E and oxidized A2E have been shown to photooxidize when exposed to blue light irradiation
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that form readily react with human BM proteins (Murdaugh, 2010; Murdaugh et al., 2009; M.
Thao, 2014; M. T. Thao et al., 2014). These protein modifications have been thought to have
deleterious effects on the functionality of BM including RPE cell attachment (Avalle et al., 2004;
M. T. Thao et al., 2014; Z. Wang et al., 2006). The observed m/z in human retinal lipofuscin wet
AMD samples indicate these A2E aldehydes not only affect proteins in the BM, but possibly the
RPE proteins as well. An accumulation of such posttranslational modifications could disrupt the
visual cycle further progressing the disease. The second trend noted that the wet AMD samples
were the only samples studied were products originating from oxidized A2E were present. These
results could lead to further investigation of oxidative stress as a prominent factor of wet AMD
onset and progression.
Inflammatory biomarkers were investigated as potential components present in human
retinal lipofuscin. Lipofuscin is the build-up of cellular waste from photoreceptor turnover in the
RPE. Presence of inflammatory biomarkers could indicate a more localized understanding of the
pathogenic mechanisms in retinal disease, specifically wet AMD, dry AMD and DR. L-citrulline
was detected in wet AMD, dry AMD and DR samples, but was not detected in the NODAM
sample. L-citrulline is an indication of iNOS activation. An up-regulation of iNOS activity can
result in a higher concentration of nitric oxide, peroxynitrite and nitrite ion. Interestingly, the
biomarker L-homocitrulline was detected predominantly in dry AMD diagnosed extracts. Lhomocitrulline has been indicated in several inflammatory diseases. Further investigation of
multiple age-matched donors should be done to further investigate the presence of Lhomocitrulline. Additionally, though the molecule was detected in NODAM and dry AMD
samples, the biomarker was significantly more prevalent in the diseased tissue when an internal
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an internal standard for quantification, but, because it is a known antioxidant, it verified the
presence of L-homocitrulline was a result of in vivo production rather than possible post-mortem
biochemical reactions. L-homocitrulline is produced through non-enzymatic carbamylation of
lysine residues and has been associated with several chronic inflammatory conditions including
atherosclerosis and rheumatoid arthritis (Gillery & Jaisson, 2014; Kaur & Halliwell, 1994;
Pruijn, 2015). Observing L-homocitrulline can lead to further investigation of chronic
inflammation as a primary cause of dry AMD and possibly can be used as a biomarker for
disease. Further differences in lipofuscin extracts indicated the wet AMD sample had observed
m/z associated with 3-nitrotyrosine and nitro-A2E. Considering how these molecules are formed
in vivo, these results could be in conjunction with iNOS activity and the byproducts of iNOS
activation. However, further work needs to be done to investigate this phenomenon in wet AMD
samples. These results could assist in understanding the pathogenesis and progression of wet
and dry AMD.
Drusen is a hallmark for dry AMD. Several proteomic studies have been conducted to
investigate the composition of drusen associated with AMD. These studies have shown that
drusen partially forms by RPE exocytosis of cellular waste, either similar to or identical to,
lipofuscin into the BM (Crabb, 2014; Crabb et al., 2002; G S Hageman, Mullins, Russell,
Johnson, & Anderson, 1999; Gregory S. Hageman et al., 2001; Mullins et al., 2000). Recent
studies have investigated the implication of CML in retinal disease. The work of Mishra et. al.
provided strong evidence that plasma levels of CML are significantly increased in patients
diagnosed with diabetic retinopathy (Mishra et al., 2016). Additionally, work done by
Roehlecke et. al. indicated CML presence in RPE cells in vitro increases apoptosis (Roehlecke et
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suggesting the presence of CML in RPE cells associated with retinal disease.
The present work indicated AGEs that have previously been exclusively identified with
drusen to also be present in lipofuscin. In particular, pentosidine, is an AGE that is highly
correlated with collagenous tissues, such as BM, and been found to be synthesized from reducing
sugars present in the ECM (Sell & Monnir, 1989). The results from this work indicated
additional similarities in RPE lipofuscin and BM drusen further agreeing that drusen may be
partially formed as a result of RPE exocytosis of molecular waste. This hypothesis may also be
supported considering results suggesting the A2E photooxidative products are predominantly
present in wet AMD samples. Wet AMD is characterized by neovascularization. Results from
Liu, J. et al indicate that under excessive oxidative stress caused by retinal damage and
neovascularization the symbiotic relationship between the RPE and BM is disrupted (Jian Liu et
al., 2013). It can be hypothesized the RPE are able to synthesize some of these AGEs that have
previously been reported to be specific to BM, which could cause additional oxidative stress to
the ECM.
Overall these compositional studies can aid in understanding retinal disease and further
identify indicators that wet and dry AMD are two different diseases. Further understanding of the
onset and pathogenesis of the two forms of AMD can identify better treatment and prevention
options. Additionally, potential biomarkers have been identified. These biomarkers can be used
to understand the early ongoing of AMD. The identification of a key inflammatory biomarker
(L-homocitrulline) in donor tissue is of particular interest as it coincides with the inflammatory
cell death explored in models systems as identified in chapter 3. Further investigation of such
biomarkers can aid in detecting AMD early and more thoroughly.

CHAPTER 5
CONCLUSIONS AND FUTURE STUDIES
AMD is projected to increase substantially over the next several decades. Clinically,
some of the symptoms of AMD include retinal cell death, excessive lipofuscin build-up and
drusen deposits near the macula. Several risk factors are believed to contribute to AMD
including aging, inflammation and oxidative stress; however, the exact onset and progression
continues to go widely unknown. This work aims to investigate the biochemical changes that
occur through examining the exact cell death mechanism of ARPE-19 cells, and further
elucidation of retinal lipofuscin to better understand the onset and progression of retinal disease,
specifically AMD. Not only is the diagnosis and the pathogenesis of AMD complicated, but also
current treatment options for AMD are limited. The extensive examination performed in this
work can assist in creating new and more effective treatment options for those suffering from
AMD.

Exploring ARPE-19 Cell Death by Modeling Aging, Inflammation and Oxidative Stress
A hallmark of AMD is retinal cell death; however, the mechanism of cell death is not
fully understood. While apoptosis and necrosis have been well-established mechanisms in the
literature, novel cell death mechanisms continue to be discovered. Apoptosis and necrosis have

been previously implicated as possible RPE cell death mechanisms (J. R. Sparrow & Cai,

216

2001; Suter et al., 2000; Z. Wang et al., 2005). Nevertheless, AMD is a multifactorial disease
and as such it can be hypothesized that more than one cell death mechanism may be initiated as a
result of aging, oxidative stress and inflammation. Understanding the biochemical pathways
leading up to cell death can assist in understanding AMD pathogenesis.
Posttranslational ECM protein modifications that have been correlated with AMD were
modeled in this study including the following: glycation as a model for aging, nitration as a
model for inflammation and A2E with and without BL irradiation as a model for oxidative stress.
In this study, we hypothesized that RPE cell death is an overlap of cell death mechanisms
between apoptosis, necrosis, pyroptosis and necroptosis. We have shown that using MTT assay,
glycation and nitration ECM modifications show a decrease in metabolic activity and
proliferation; however, differ widely in the cell viability studies. Non-enzymatic nitration of the
ECM indicated non-viable ARPE-19 cells were in early apoptosis and late apoptosis/necrosis.
Inhibition cell viability studies showed significant ARPE-19 cell death recovery for nitrated
ECM with cas-3 and nec-1 inhibitors. Non-enzymatic glycation, using glycolaldehyde, ECM
modification indicated non-viable ARPE-19 cells were in early apoptosis; however, when cell
death inhibitors were added, a significant recovery occurred with every inhibitor. Modifications
to the ECM mediated by A2E and blue light irradiated A2E indicated most of the non-viable
ARPE-19 cells were in a state of late apoptosis and necrosis. When inhibitors were added to
A2E dark ECM modifications, significant ARPE-19 cell death recovery occurred with cas-3 and
nec-1. In contrast, A2E + BL modifications results indicated a significant cell death recovery
with all inhibitors. Repeating these studies is key to validating these results.

Future studies of this work would be to investigate the degree of glycation in
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association with cell death mechanism. It has been shown that increased glycation reduces cell
attachment, however the exact cell death mechanism has not been investigated. This would be of
particular interest considering the observed recovery of cell death with all inhibitors in the
glycated ECM. It would also be of great interest to expand the cell death mechanisms
investigated to include Anoikis and caspase-9-dependent apoptosis. As previously discussed in
Chapter 1, apoptosis is a complicated cell death mechanism that can involve intrinsic, extrinsic
or both apoptosis pathways. One type of apoptosis that involves both intrinsic and extrinsic
pathways is Anoikis where cell death is the result of the cell being unable to attach to the ECM.
Given the symbiotic relationship between the retinal pigment epithelium and Bruch’s Membrane,
Anoikis would be an interesting addition to this work. Caspase-9 dependent apoptosis would
also be a continuation of this work in cell death mechanisms of RPE cells. Caspase-9 is
activated in response to intracellular stress signals and is thus involved in the intrinsic pathway
of apoptosis. Considering the research discussed in Chapter 4 of this work, the RPE may harbor
molecules that induce stress within the RPE cell. Apoptosis was a cell death mechanism
identified when conducting this work for several of the ECM modifications presented. By further
probing and investigating the various pathways of apoptosis, evidence can be obtained that is
conducive to answering the question: What is triggering RPE cell death in AMD patients?

Further Elucidation of Human Retinal Lipofuscin Associated with AMD
Excess retinal lipofuscin has been shown to increase with the onset of AMD; therefore,
the elucidation of the components within lipofuscin has been a high interest of study. There has
been a large debate on the commonality of dry AMD and wet AMD onset and progression.
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treated as two different diseases (Chong et al., 2005; Gregory S. Hageman et al., 2001; Mullins
et al., 2000; Sohn et al., 2014). Diabetic retinopathy has also been investigated in conjunction
with wet AMD due to the similar clinical characteristic of choroidal neovascularization
(Ishikawa, Jin, Sawada, Abe, & Yoshitomi, 2015; Kuiper et al., 2008). A2E has been one of the
most widely studied components detected in retinal lipofuscin. As newly revealed research has
shown, A2E may be less present in the macula than previously thought (Ablonczy et al., 2013).
However, several studies have provided support for the effects of highly reactive photochemical
properties of A2E and the detrimental products that are derived from these reactions may have
on the retina (J. Dillon et al., 2004; James Dillon et al., 2004; Liebmann, Born, & KolbBachofen, 2010; Janet R. Sparrow et al., 2000; M. T. Thao et al., 2014; Z. Wang et al., 2006).
Eldred, G. demonstrated strong evidence that A2E inhibits lysosomal protein degradation
(Eldred, 1995). Additionally, AGE accumulation and inflammation have been implicated as
underlying factors for AMD (Blasiak et al., 2014; Murdaugh et al., 2011; Nowak, 2006).
Therefore, the products of reactions between protein residues and A2E, inflammatory biomarkers
and AGE prevalence were investigated as components of lipofuscin extracts from tissue obtained
from donors diagnosed with wet AMD, dry AMD or DR.
Human retinal lipofuscin extracts were examined to identify components prevalent in wet
AMD, dry AMD and DR samples. We have shown that A2E and oxidized A2E were indicated
to have no preferential accumulation in a particular disease; however, the photooxidative
products were widely observed in wet AMD samples as compared to dry AMD and DR samples.
Additionally, our results indicated there was no observation of components derived from the
photooxidation of furan-A2E other than wet AMD. While these results were observed in
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interest to determine the concentration of these products in association with wet and dry AMD.
Additionally, expanding the A2E photooxidation product reactions with lysine and arginine to
determine if the same trends continue while also investigating additional protein residues would
be of interest to study.
Inflammatory biomarkers were investigated as potential components present in human
retinal lipofuscin. Our results indicated the presence of L-citrulline in wet AMD, dry AMD and
DR samples. Interestingly, the biomarker L-homocitrulline was detected in dry AMD samples
but not wet AMD nor DR samples. Further differences in lipofuscin extracts indicated wet AMD
samples had observed m/z associated with 3-nitrotyrosine and nitro-A2E. This could be in
conjunction with iNOS activity. Additional studies to investigate the activation and presence of
iNOS activity biomarkers would be of interest. Nitrated tyrosine is considered a hallmark of
peroxynitrite (ONOO-) activity. It has been postulated that in a hypoxic environment, iNOS
derived nitric oxide leads to the formation of L-citrulline. However, when nitric oxide is in the
presence of a superoxide radical (O2-), ONOO- can form; thus, prompting the nitration of
tyrosine residues (Buttery & Polak, 1999; Winrow & Blake, 1999). The observation of Lcitrulline and 3-nitrotyrosine in particular samples may shed light on not only the impact of but
also the relationship between inflammation and oxidative stress within the retina.
These results could assist in understanding the pathogenesis and progression of AMD,
particularly the difference in the onset of wet AMD compared to dry AMD. Further elucidation
of the observed m/z structures should be conducted. These studies would include isolation and
purification of the molecules of interest from the lipofuscin and subjecting the products to NMR
and IR spectroscopy.

AMD is poorly understood, thus it is not surprising that there are little to no effective 220
treatment options. The work discussed in Chapter 4 revolved around human tissue samples. This
work together with the model systems discussed in Chapter 3 allows the scientific community
studying ocular disorders to gain a better understanding of AMD that can lead to better treatment
and prevention. What is known about AMD is that it is becoming increasingly widespread, has
debilitating effects on patients worldwide and it is multifactorial. The exact pathogenesis and
progression of AMD continue to evade scientists, however this work attempts to illuminate these
questions by focusing on two intriguing characteristics of AMD (cell death and lipofuscin) with
the aim of extracting valuable information. It was determined that the cell death mechanism of
RPE cells has overlapping pathways and may be caused by ECM stress. It was further
determined that the RPE lipofuscin, known to significantly build-up in the retina of an AMD
patient, may hold key features of understanding the disease including biomarkers and
intracellular stresses. This work has been able to probe questions on the development of AMD
while also providing the opportunity and basis for more specific questions to be asked in the
future. Overall, this work can prove to be a vital portion of accomplishing the monumental task
of understanding the pathogenesis, progression and treatment development for AMD.
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